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ABSTRACT 
Diabetes is associated with increased psychological distress which, in turn, is associated 
with poorer diabetes outcomes.  This study examined the impact of a nine-week Internet-
based cognitive-behavioral therapy intervention that targeted stress and mood in people 
with diabetes.   It was hypothesized that the intervention would decrease psychological 
distress and improve diabetes outcomes and adherence to diabetes treatment regimens.  
Participants with type 1 and type 2 diabetes were randomly assigned to the intervention 
(n = 103) or a waiting-list control group (n = 74).  ANCOVAs demonstrated significant 
group effects for the reduction of perceived generalized stress (F (1, 105) = 7.06, p = .01; 
d = .84), diabetes-related distress (F (1, 105) = 13.45, p < .01; d = .54), depression (F (1, 
90) = 7.06, p < .01; d = .40), anxiety (F (1, 89) = 6.78, p = .01; d = .41), and negative 
affect (F (1, 103) = 13.02, p < .01; d = .56).  There were also significant group effects for 
the reduction of psychological fatigue (F (1, 98) = 7.34, p = .01; d = .40), cognitive 
symptoms (F (1,95) = 6.40, p = .01; d = .48), hyperglycemic symptoms (F (1, 95) = 
11.16, p <.01; d = .41) and hypoglycemic symptom (F(1, 98) = 6.16, p = .02; d = .53).  
Further, there were significant indirect effects of the intervention on the above diabetes 
symptoms, through psychological distress.  There was no effect of the intervention on 
hemoglobin A1c (F(1.43) = 0.28, p = .60), though this analysis was underpowered.  The 
intervention also had no effect on adherence to diabetes treatment regimen.   This study 
provides evidence of a convenient and effective way to reduce psychological distress and 
vii 
improve symptoms in those with diabetes.  It also provides evidence of reduced 
psychological distress as a mechanism for improving diabetes outcomes.    
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Chapter One 
Introduction 
Over 29 million Americans, 9.3% of the country’s population, have Diabetes Mellitus, an 
endocrinological disease that reduces the pancreas’ ability to produce or effectively use insulin, 
the hormone needed to regulate glucose (Centers for Disease Control and Prevention, 2014; 
Hampson et al., 2001).  Uncontrolled diabetes substantially increases the risk for a variety of 
serious medical complications that affect the eyes, kidneys, nerves, and cardiovascular system 
(Goldstein et al., 2004; Landell-Graham, Yount, & Rudnicki, 2003) and it is the seventh leading 
cause of death in the United States (Centers for Disease Control and Prevention, 2014). There is 
also evidence that psychological distress is more prevalent in people with diabetes (Anderson, 
Freedland, Clouse, & Lustman, 2001; Eaton, 2002; Fenton & Stover, 2006; Lustman, Griffith, 
Clouse, & Cryer, 1986; Scott et al., 2007). Further, researchers have demonstrated that those 
with diabetes who are also experiencing psychological distress have worse adherence and 
glycemic control, more medical complications, higher hospitalization rates, and die at an earlier 
age (Anderson et al., 2001; Ciechanowski, Katon, & Russo, 2000; de Groot, Anderson, 
Freedland, Clouse, & Lustman, 2001; de Groot, Jacobson, Samson, & Welch, 1999; Egede, 
2006; Gilmer et al., 2005; Grandinetti et al., 2000; Lustman & Clouse, 2005; Lustman et al., 
1986; Niemcryk, Speers, Travis, & Gary, 1990; Wrigley & Mayou, 1991).  Reducing 
psychological distress in people with diabetes may lead to improvements in their physical and 
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psychological health, though the mechanisms involved in this relationship are not well 
understood. 
Diabetes Mellitus & Glycemic Control 
Diabetes Mellitus is a disease of the endocrine system that affects the pancreas’ ability to 
produce or effectively use insulin, the hormone needed to regulate glucose in the body (Hampson 
et al., 2001).  There are two types of diabetes, which are differentiated by their patterns of onset, 
etiology, and treatment regimens (de Groot et al., 1999).  Type 1 diabetes is the result of 
autoimmune destruction of the pancreas’ beta cells, which usually occurs early in life.   The lack 
of beta cells eliminates the body’s ability to produce insulin, requiring patients to rely completely 
on exogenous forms of insulin for survival.  Patients with type 1 diabetes must monitor blood 
glucose levels and regulate the levels by injecting insulin several times each day (Van Tilburg et 
al., 2001).   
Type 2 diabetes is usually diagnosed later in life, subsequent to the pancreas becoming 
unable to produce enough insulin or the body’s inability to effectively use the insulin to control 
glucose levels (American Diabetes Association, 2010; Van Tilburg et al., 2001).  A patient with 
type 2 diabetes must enhance the body’s ability to use insulin and supplement the pancreas’ 
production of insulin with the aid of oral medication and, sometimes, insulin injections.  
However, many type 2 diabetics are able to regulate their glucose levels by following a healthy 
diet plan (Van Tilburg et al., 2001). 
The primary goal in the treatment of diabetes is achieving good glycemic control, i.e., 
reducing blood glucose to a healthy level that is then maintained (Goldstein et al., 2004; Qaseem 
et al., 2007).  This is accomplished through successful diabetes management, which may include 
a healthy diet, exercise, oral medications and/or insulin injections and careful monitoring of 
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glucose (American Diabetes Association, 2010).  Hemoglobin A1c (A1c) provides a reliable 
index of glucose regulation over a period of two to three months (Goldstein et al., 2004; 
Lustman, Griffith, Freedland, & Clouse, 1997).  A1c describes the amount of glucose that is 
bound to red blood cells (RBCs) over the course of their lifespan, which is typically 90-120 days 
(Goldstein et al., 2004). As RBCs reach the end of their lifespan they will have less influence on 
the A1c value and the newest RBCs will have the greatest influence.  Thus, A1c is a weighted 
average of glucose control, with the glucose concentrations of the previous month contributing 
about 50% to the A1c value (Rohlfing et al., 2002).  A high A1c level is indicative of poor 
glycemic control.  It is generally recommended that A1c be as low as possible without causing 
hypoglycemic complications, for most diabetics this is less than 7% (American Diabetes 
Association, 2010; Qaseem et al., 2007).  Prolonged poor glycemic control results in diabetic 
complications, such as retinopathy, neuropathy, and nephropathy, and increased mortality (Katon 
et al., 2005).  Decreasing A1c by 1% decreases the risk of some complications by as much as 
33% to 40% (Centers for Disease Control and Prevention, 2008; Lustman, Anderson, et al., 
2000).  Therefore, it is important to understand the factors that influence the maintenance and 
deterioration of glycemic control.   
Diabetes & Psychological Distress 
Psychological distress is more common in people with diabetes than in the general 
population (Anderson et al., 2001).  This was demonstrated in a study that examined 114 
individuals with type 1 and type 2 diabetes.  In this sample, 71% of the diabetes patients met 
criteria for a psychiatric diagnosis at some point in their lifetime.  The most common diagnoses 
were major depressive episode (33%) and generalized anxiety disorder (41%; Lustman et al., 
1986).  Similarly, in an international sample of over 42,000 people, diabetes was associated with 
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depression, anxiety, and comorbid depression and anxiety (Scott et al., 2007).  A meta-analysis 
of 20 studies concluded that people with diabetes were twice as likely to have depression as non-
diabetics (Anderson et al., 2001).  Women with diabetes are particularly at risk for depression 
(Anderson et al., 2001).   Cross-sectional studies have indicated that 44% of women with Type 2 
diabetes report a depressed mood and 34% report a history of diagnosed depression (Whittemore, 
Melkus, & Grey, 2004); this is substantially higher than the 10% to 25% lifetime prevalence that 
is found in community samples (American Psychiatric Association, 2000). Even individuals that 
do not meet criteria for a psychological disorder experience high levels of distress.  In fact, the 
diagnosis of diabetes often provokes stress related to difficulties following the intense diabetes 
management regimen and the possibility of short-term (e.g., hypoglycemic episodes) and long-
term complications (e.g., neuropathy; Gonder-Frederick, Cox, & Ritterband, 2002).   
Diabetes patients who meet criteria for a psychological diagnosis describe their overall 
physical functioning as poor (Ciechanowski, Katon, Russo, & Hirsch, 2003).  They also report 
more symptoms of diabetes (Ciechanowski et al., 2003; Lustman et al., 1986) and more distress 
related to the symptoms (Lustman et al., 1986).  One meta-analysis of 27 studies found a 
significant association between depression and diabetes complications, including retinopathy, 
nephropathy, neuropathy, macrovascular complications and sexual dysfunction (de Groot et al., 
2001).  In addition, diabetics with depression have more risk factors for cardiovascular disease 
(Katon, Simon et al., 2004), including higher rates of obesity and smoking (Katon, Simon, et al., 
2004).   
Psychological distress is also related to poorer glycemic control.  Multiple studies have 
demonstrated higher A1c levels in diabetics who are depressed (de Groot et al., 1999; 
Grandinetti et al., 2000; Lustman & Clouse, 2005) and anxious (Lustman et al., 1986; Niemcryk 
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et al., 1990).  Diabetics with dangerously high A1c requiring hospitalization complain of more 
depression and tension (Wrigley & Mayou, 1991).  They also report more stressful life events 
(e.g., moving houses, job loss) and chronic stressors (e.g., marital problems, caring for an ill 
loved one), compared to diabetics who do not require hospitalization (Wrigley & Mayou, 1991).  
Similarly, severe personal stressors such as problems with a spouse or child or death of a parent, 
have been associated to deteriorating glycemic control (Lloyd et al., 1999).  A longitudinal study 
of type 1 diabetics demonstrated that negative stress (e.g., interpersonal conflicts, death of 
friend) was related to reduced glycemic control over time (Lloyd et al., 1999).    
The Link Between Diabetes & Psychological Distress 
The causal relationship between diabetes and psychological distress is still not well 
understood.  Some research suggests a “consequence model,” which posits that the experience of 
having diabetes (e.g., coping with adherence to medical recommendations or diabetes related 
medical symptoms) may create psychological distress (Kovacs, Goldston, Obrosky, & Bonar, 
1997; Palinkas, Barrett-Connor, & Wingard, 1991; Sacco & Bykowski, 2010).  However, other 
evidence supports an “antecedent model,” which suggests that psychological distress contributes 
to poor glycemic control (Lustman, Clouse, Ciechanowski, Hirsch, & Freedland, 2005; 
Musselman, Betan, Larsen, & Phillips, 2003; Surwit & Schneider, 1993; Van Tilburg et al., 
2001).  With regard to the antecedent model, research has focused on two primary paths through 
which psychological distress may influence glycemic control.  These involve physiological and 
behavioral consequences of distress.   
Psychological distress, such as stress and depression, has been implicated in 
hypothalamic-pituitary-adrenal (HPA) axis activation (Black, 2006).  When the body is under 
stress, the hypothalamus in the brain releases corticotropin-releasing hormone (CRH).  This 
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hormone stimulates the production of corticotropin (ACTH) from the anterior pituitary gland, 
which causes the adrenal cortex to release cortisol into the body (Black, 2006; Rosmond, 2005).   
Cortisol inhibits insulin secretion as well as its ability to regulate glucose (Rosmond, 2005), 
increasing circulating glucose levels and leading to poor glycemic control.   
The behavioral pathway emphasizes the importance of adherence to a rigorous diabetes 
treatment regimen.  Psychological stress is one of the four factors that have been identified as 
predictors of successful self-care behaviors in patients with type 2 diabetes, along with patient 
characteristics, the doctor-patient relationship, and the social context (Albright, Parchman, 
Burge, & the RRNeST Investigators, 2001).  Those who experience distress may feel that self-
care behaviors important to diabetes management may be too difficult or they may not be 
motivated to perform the necessary tasks (Lloyd, Smith, & Weinger, 2005).    Researchers have 
found that diabetes patients with high levels of depression or stress tend to have poorer diets, 
participate in less physical activity (Albright et al., 2001; Lin et al., 2004), and are more likely to 
smoke (Ciechanowski et al., 2003; Lin et al., 2004) than those who report less distress.  In 
addition, depressed patients are more likely to be non-adherent to diabetes medications as well as 
lipid-lowering and anti-hypertensive medication (Lin et al., 2004).  People with higher levels of 
depressive symptomatology skip their medication more often than those with fewer depression 
symptoms (Ciechanowski et al., 2000).  This lack of adherence and increase in unhealthy 
behaviors has harmful effects on diabetes management, leading to poor glycemic control (Peyrot, 
McMurry, & Kruger, 1999). 
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Can Reducing Psychological Distress Improve Glycemic Control? 
Given that depression and other forms of psychological distress have been associated 
with decreased glycemic control, researchers have begun to ask whether treating psychological 
distress can lead to better glycemic control (Katon, Von Korff, et al., 2004; Lustman & Clouse, 
2002; Surwit et al., 2002). There are various forms of treatments for psychological distress that 
have been shown to be efficacious, including psychopharmacological treatments (e.g., selective 
serotonin reuptake inhibitors, tricylclic antidepressants), cognitive–behavioral therapy (CBT), 
and relaxation training (Lambert & Ogles, 2004).  Many of these interventions have been 
examined in people with diabetes.  One recent meta-analysis of 30 studies concluded that 
interventions that target psychological distress significantly reduce A1c in people with diabetes 
(d = 0.18; 95% CI [0.03, 0.33]), an effect that is equivalent to approximately a 0.32% decrease in 
A1c (Bykowski, Sacco, & Mayhew, 2011).  Although the effect of psychological distress 
interventions is relatively small, a decrease in A1c by 1% reduces the risk of some serious 
medical complications by as much as 40% (Centers for Disease Control and Prevention, 2008).  
Thus, psychological distress interventions could possibly reduce the risk of diabetes 
complications by as much as 10%.  
While a lack of power in this meta-analysis limited the ability to detect significant 
differences between studies that targeted different types of distress, the 11 intervention studies 
that targeted stress interventions had a mean effect size that was higher than the effect size for 
interventions that targeted depression, poor coping, binge eating, and general distress (Bykowski, 
Sacco, & Mayhew, 2011).  These stress management interventions included group (Aikens, 
Kiolbasa, & Sobel, 1997; Attari, Sartippour, Amini, & Haghighi, 2006; Henry, Wilson, Bruce, 
Chisholm, & Rawling, 1997; Karlsen, Idsoe, Dirdal, Hanestad, & Bru, 2004; Tsujiuchi et al., 
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2002; van Rooijen, Rheeder, Eales, & Becker, 2004) and individual (Feinglos, Hastedt, & 
Surwit, 1987; Lane, McCaskill, Ross, Feinglos, & Surwit, 1993; McGinnis, McGrady, Cox, & 
Grower-Dowling, 2005; McGrady, Graham, & Bailey, 1996; McGrady & Horner, 1999) 
interventions that utilized relaxation exercises (e.g., progressive muscle relaxation, guided 
imagery) and/or cognitive-behavioral techniques to alleviate stress in people  with type 1 and 
type2 diabetes.   
These intervention studies hypothesized that the reduction of distress leads to improved 
glycemic control. Unfortunately, this mechanism was not tested in most of the studies.  Some 
researchers focused only on the effect of the intervention on glycemic control and did not 
examine post-intervention distress, and the majority of those that included post-intervention 
psychological assessments did not examine the relationship between these assessments and 
changes in A1c. These methodological limitations do not allow for conclusions about whether a 
reduction in distress mediates the improvement in glycemic control. 
However, there is some evidence that intervention-induced reductions in psychological 
distress may mediate reductions in A1c.    In their study on the effect of acceptance and 
commitment therapy, Gregg, Callaghan, Hayes, & Glenn-Lawson (2007) found that post-
intervention acceptance mediated the effect of the treatment on A1c.  Similarly, a path analysis 
by Lustman and colleagues (1997) indicated that treatment with nortriptyline led to a change in 
BDI scores, which led to a change in A1c. In another study, Lustman and colleagues (Lustman, 
Griffith, Freedland, Kissel, & Clouse, 1998) described lower A1c in participants who were no 
longer depressed following 10 weeks of CBT, compared to those who remained depressed. 
However, this was not replicated in a study of fluoxetine (Lustman, Freedland, Griffith, & 
Clouse, 2000), in which the glycemic control indices of participants who responded to treatment 
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with fluoxetine (i.e., had lower BDI scores) were not different from those of non-responders.  
Finally, while Kendardy et al. (2002) did not find a difference in binge eating frequency between 
the control and intervention groups after 10 weeks of CBT, they did note that a reduction in 
binge eating frequency was related to a reduction in A1c.  
  The mechanisms by which distress reduction lead to improved glycemic control have also 
been largely ignored.  As noted earlier, antecedent models suggest a behavioral pathway that 
emphasizes the negative effect of distress on adherence to a rigorous diabetes treatment regimen.  
If distress inhibits self-care behaviors (Lloyd et al., 2005), alleviating distress may improve the 
self-care behaviors, which ultimately should improve glycemic control.   Unfortunately, only one 
intervention study has provided evidence in support of this pathway.  Post-intervention 
adherence mediated the effect of acceptance and commitment therapy on lower A1c (Gregg et 
al., 2007).  Therefore, additional research should aim to clarify the role of the behavioral 
pathway in the relationship between distress and glycemic control.    
In summary, there is evidence that interventions aimed at alleviating psychological 
distress may also improve diabetes management and glycemic control in individuals with 
diabetes.   This is not surprising given the strong association between psychological distress and 
glycemic control (Lustman, Anderson et al., 2000). However, the mechanisms that drive the 
effect are rarely studied, leaving many questions about whether distress reduction is responsible 
for improved diabetes outcomes and whether this effect is mediated by improved adherence.  
Preliminary data thus support the utility of including psychological distress interventions as part 
of a comprehensive diabetes management program; however, further elucidation of the 
mechanisms will provide more information about how and why they are useful. 
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This study examined the relationship between psychological distress and diabetes 
outcomes, including diabetes symptoms and glycemic control.  It evaluated the antecedent 
model, which posits that psychological distress leads to poor diabetes outcomes. It was 
hypothesized that psychological distress interventions would reduce psychological distress, 
which would improve diabetes outcomes in people with diabetes.  Further, improved adherence 
was expected to mediate the effect of the intervention on diabetes outcomes. 
Barriers to Psychotherapy 
 Despite the evidence that psychotherapy is effective at reducing various types of 
psychological distress (Lambert & Ogles, 2004), these interventions are underutilized.  There are 
many reasons for the discrepancy between the number of people that would benefit from 
psychological services and the number that seek or receive services. Perhaps the most salient 
reason for most potential clients is the stigma associated with mental disorders (Cuijpers, van 
Straten, & Andersson, 2008).  Individuals may be afraid of what others will think or of how they 
might be judged because they are participating in psychotherapy.  People may also have negative 
feelings about therapists and they may be uncomfortable or unwilling to talk to a stranger about 
their personal problems (Cuijpers et al., 2008).  These societal and personal issues prevent many 
people from engaging in psychotherapy, despite their need for services. 
There may also be logistical problems that do not make psychotherapy possible for some 
individuals.  For example, for individuals that live in rural or underdeveloped areas, the nearest 
therapist may be too far away.  Other clients may not have the ability to procure transportation to 
a therapist (Cuijpers et al., 2008).  It may also be difficult or impossible for clients to take the 
time off of work to see a therapist or to find child care (Cartreine, Ahern, & Locke, 2010).  
People who have comorbid health problems may also have physical limitations that make 
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traveling to a therapist’s office difficult (Cuijpers et al., 2008).  In addition, many people do not 
have the financial resources or medical insurance to cover the cost of psychotherapy (Cartreine et 
al., 2010). 
Computerized Psychological Distress Interventions 
 Technology has provided a way to overcome many of the barriers to psychotherapy.  
Some therapists have begun to offer computerized psychological interventions.  These include 
interventions that are available as computer programs that are installed on a client’s computer 
(e.g., from a CD-ROM) or accessed via the Internet.  These interventions are often client-driven, 
with little to no contact with a therapist.  Many are based on cognitive-behavioral therapy (CBT).  
CBT is ideal for this type of therapy because the structure and presentation of CBT are easily 
presented in text and CBT interventions are effective for many types psychological disorders 
(Cuijpers et al., 2008; Spek et al., 2007).   
Computerized CBT (CCBT) can yield benefits for both the therapist and client.  The 
decrease in therapist contact allows more time to see clients and results in shorter waiting lists 
(Cuijpers et al., 2008; Marks et al., 2003; Spek et al., 2007). One clinic that incorporated CCBT 
into its practice noticed shorter waiting lists for face-to-face therapy and increases in the number 
of clients they were able to treat.  The therapists at this clinic spent less time per patient but the 
benefits to the patients were similar to those of face-to-face therapy (Marks et al., 2003).    
Clients also benefit from the anonymity that CCBT provides (Spek et al., 2007; Tate & 
Zabinski, 2004).  The ability of clients to access the intervention from their homes can overcome 
the shame that is a result of the stigma that is often associated with psychotherapy (Cuijpers et 
al., 2008; Griffiths, Lindenmeyer, Powell, Lowe, & Thorogood, 2006; Tate & Zabinski, 2004).  
Participants tend to be less self-conscious and more likely to disclose information about 
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themselves via the computer, as compared to face-to-face interactions (Marks et al., 2003; Tate 
& Zabinski, 2004).  In fact, clients who have used computer-aided self help have admitted that 
they revealed sensitive information to the computer that they would not have told a person 
(Marks et al., 2003).  There may also be a reduced tendency for clients to respond in a certain 
way due to social desirability (Tate & Zabinski, 2004), making assessment more accurate and 
therapy more productive.   
 Clients also appreciate the convenience that these interventions provide.  They save time 
because they do not have to spend time traveling to the therapist’s office and do not have to 
schedule appointments at a time convenient for both the client and therapist (Cuijpers et al., 
2008; Griffiths et al., 2006; Spek et al., 2007; Tate & Zabinski, 2004).  Some studies have 
identified the constant availability of the intervention to be among the most important assets of 
the therapy.  In fact, research on CCBT interventions finds that the majority of participants 
access the programs during traditionally non-clinic hours (Tate & Zabinski, 2004). CCBT also 
provides a way for clients who are isolated (due to location or medical limitations) to access 
therapy (Griffiths et al., 2006) and reduces the cost of psychotherapy, increasing the availability 
of psychotherapy in low socioeconomic groups  (Marks et al., 2003).   
The qualities of CCBT interventions also provide advantages over traditional, face-to-
face psychotherapy.  The interactive and audiovisual capabilities may increase clients’ 
motivation to use the program.  In addition, clients may feel empowered by the ability to go 
through the information on their own (Ritterband et al., 2003) and work at their own pace to 
assure that they understand the concepts that are presented (Cuijpers et al., 2008).  The client 
also has the ability to go back to the program and review important information (Spek et al., 
2007).  Another therapeutic benefit to CCBT is that it provides an easy way to implement routine 
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assessments of client progress, information that is valuable to both the client and therapist 
(Cuijpers et al., 2008).   
 Some negative aspects of CCBT, such as poor compliance and increased attrition, have 
been identified in various research studies (Ritterband et al., 2003).  It may be easier for a client 
to disengage from a web-based therapy program than to cancel an appointment with a “real 
person” (Spek et al., 2007; Tate & Zabinski, 2004).  In addition, fully automated programs are 
limited in that they may not be able to address all concerns that are important to clients (Cuijpers 
et al., 2008; Tate & Zabinski, 2004) and cannot detect subtle, nonverbal cues that indicate that 
the client is misunderstanding a concept (Cuijpers et al., 2008).  Others have suggested that 
having clients interact with a machine may be impersonal or dehumanizing (Spek et al., 2007; 
Wright & Wright, 1997).  Despite these potential disadvantages, many clients report that they are 
satisfied with these types of treatments (Marks et al., 2003).   
Efficacy of CCBT 
While CCBT is a relatively new treatment, several studies have shown it to be a feasible 
and efficacious treatment for many types of disorders.  Several qualitative and quantitative 
reviews have supported the use of CCBT for the treatment of depression and anxiety (Spek et al., 
2007).  A meta-analysis of randomized controlled trials (RCT) examining the efficacy of CCBT 
for the treatment and/or prevention of depression and anxiety identified twelve studies with an 
overall moderate effect size (d = 0.51).  The five studies of CCBT for the treatment/prevention 
of depression had a fairly small effect size that was still significant (d = 0.22).  However, the 
seven RCTs for the treatment/prevention of anxiety had a large overall mean effect size of d  = 
0.96 (Spek et al., 2007).  
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Another meta-analysis of Internet or computer-based treatments for anxiety also 
demonstrated the efficacy of the treatment over waitlist and placebo control groups (Reger & 
Gahm, 2009).  These computerized programs resulted in improvements in anxiety, depression, 
general distress, dysfunctional thinking, and functioning in individuals with panic disorder, 
phobias, PTSD, and other anxiety symptoms.  Further, the Internet- or computer-based 
treatments yielded improvements that were similar or better than traditional face-to-face therapy 
provided by a therapist (Reger & Gahm, 2009). 
The growing literature that supports that use of CCBT for the treatment of anxiety and 
depression has influenced the treatment recommendations from the National Institute for Health 
and Clinical Excellence in the United Kingdom.  They have recently added several CCBT 
programs (i.e., “Beating the Blues” and “FearFighter”) to their recommendations for the 
treatment of panic disorder and generalized anxiety disorder in primary, secondary, and 
community care and depression in primary and secondary care.  It is considered a valid 
alternative to initial interventions in primary care, which is step 2 of a stepped-care approach 
(National Institute for Health and Clinical Excellence, 2006).  CCBT is one of the low-intensity 
interventions that is suggested for individuals with persistent, subthreshold depressive symptoms, 
or mild to moderate depression.  These recommendations are for individuals with and without a 
chronic medical condition (National Institute for Health and Clinical Excellence, 2009).  
  Few published studies have examined the effects of Internet-based stress management 
programs. A search identified only two published studies, however, both provide encouraging 
results.    Zetterqvist and colleagues (Zetterqvist, Maanmies, Strom, & Andersson, 2003) 
conducted an RCT of an Internet-based stress management program in 63 participants that 
registered via a website.  The program included six modules that were each composed of three 
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sections: relaxation, additional exercises, and information.  The relaxation section explained 
progressive relaxation, conditioned relaxation, differential relaxations, cue-controlled relaxation, 
and applied relaxation.  Participants were able to hear the instructions on the website, download 
an audio-recording, or print the written instructions for the exercises.  They were told to practice 
the techniques throughout the week.  Each week they signed on to a website to report the 
frequency and duration of their relaxation practice.  The additional exercises section contained 
information on problem solving, time management, and cognitive and behavioral responses to 
stress.  Participants were told to apply what they had learned to a topic in their life and complete 
an exercise form, which was submitted to a database.  Completion of the relaxation practices and 
exercise form was necessary to receive access to the next module.  The information sections 
were optional and included information on sleep management, eating habits, exercise, stress at 
work, positive activities, and setting limits.  The participants were given access to the program 
coordinators for help with technical difficulties or for further feedback on stress management 
issues (Zetterqvist et al., 2003).  Results included a significant group by time interaction effect, 
which indicated that, compared to the control group, the intervention group improved more on 
scores of stress, depression and anxiety (Zetterqvist et al., 2003).   
A second RCT examined the effectiveness of an Internet-based CCBT program for stress 
management in 309 employees of a major technology company (Billings, Cook, Hendrickson, & 
Dove, 2008).  This study employed the Stress and Mood Management program, which is an 
interactive website that provides education about managing stress, preventing mood problems, 
and identifying and seeking treatment for anxiety and depression if necessary.  The program used 
cognitive-behavioral techniques such as goal setting, problem-solving, identifying and 
challenging negative thoughts, relaxation, and time management.  There are multiple self-
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assessments that allow the user to determine which parts of the program are most relevant to 
them.  Participants were granted access to the entire program and worked through it at their own 
pace.  They were encouraged to explore the content areas that were most relevant to them and to 
return to the program as necessary within a three-month period.  Self-report questionnaires 
completed at the end of three-month period indicated that the program was underutilized.  Only 
3% of the participants in the intervention group accessed the stress management material four or 
more times and 65% viewed the material only once.  The depression, anxiety, and treatment 
material were accessed even fewer times.   Despite the minimal contact with the program, the 
intervention group experienced a significant reduction in stress compared to the wait-list control 
group.  However, there were no group differences in depression, anxiety, and mood (Billings et 
al., 2008). 
In summary, CCBT interventions provide a way to overcome many barriers to treatment 
and are effective for a wide range of problems (Ritterband, Andersson, Christensen, Carlbring, & 
Cuijpers, 2006).  The data in support of CCBT for the treatment of anxiety and depression are 
quite strong (Cuijpers et al., 2008; Kaltenthaler, Parry, Beverly, & Ferriter, 2008; Reger & 
Gahm, 2009; Spek et al., 2007).  There have been few studies of CCBT stress management 
programs but the two that were identified have shown improvements in stress, even when the 
majority of participants did not access the program more than once (Billings et al., 2008; 
Zetterqvist et al., 2003).. 
Can a Stress Management CCBT Intervention Improve Diabetes Management? 
 The increased prevalence of psychological distress in individuals with diabetes has been 
well-established (Anderson et al., 2001), as has the impact of distress on diabetes management 
and glycemic control (Lustman, Anderson, et al., 2000).  Intervention studies have demonstrated 
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that treatments designed to alleviate psychological distress also improve glycemic control in 
people with diabetes (Bykowski, Sacco, & Mayhew, 2011).  However, many people do not seek 
psychological services due to the stigma associated with mental illness, lack of time, insufficient 
finances, or various other reasons (Cartreine et al., 2010; Cuijpers et al., 2008).  Internet-based 
CCBT interventions have overcome many of these barriers and have demonstrated efficacy in 
alleviating psychological distress (Billings et al., 2008; Cuijpers et al., 2008; Kaltenthaler et al., 
2008; Reger & Gahm, 2009; Spek et al., 2007; Zetterqvist et al., 2003). Internet-based diabetes 
education and self-management interventions have been shown to be effective at improving 
glycemic control and self-management over a one year period (Lorig, Ritter, Laurent, & Plant, 
2006; McMahon et al., 2005).  However, there are few Internet-based CCBT interventions that 
have been employed to treat psychological distress in people with diabetes.  Given the impact 
that these interventions can have on controlling diabetes, it is important to examine the use of 
Internet-administered interventions as an adjunct to a comprehensive diabetes management 
program. 
 One group of researchers has addressed this need through a randomized trial of a web-
based well-being intervention for adults over the age of 60 diagnosed with type 1 or type 2 
diabetes for least one year (Bond, Burr, Wolf, & Feldt, 2010). The objective of the intervention 
was to improve diabetes self-management and psychosocial well-being.  Behavioral and 
motivational strategies were used to emphasize the patient’s role in maintaining health, 
highlighting the importance of setting goals and using problem-solving skills to overcome 
obstacles to goals and improve self-efficacy.    Participants were educated in diabetes 
management, diet, exercise, and interventions to deal with the physical and emotional demands 
of diabetes.  This program also included a great deal of interaction with a study nurse and other 
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participants via instant messaging, chat, email, and a bulletin board.  Participants also utilized a 
study website to enter blood glucose readings, exercise programs, weight changes, blood 
pressure and medication data.  The nurse reviewed the information provided by the patients and 
provided feedback when necessary to resolve problematic changes.  All participants also 
participated in a weekly online discussion group that provided educational material to the group 
and promoted peer support and social interaction.  Following the six-month intervention, the 
treatment group demonstrated less depression, improved quality of life, increased self-efficacy, 
and increased social support compared to a treatment-as-usual control group.  In addition, the 
treatment group showed significantly more improvement in A1c, HDL, total cholesterol, weight, 
and systolic blood pressure (Bond et al., 2007).   
While this study shows great promise for incorporating a well-being intervention into a 
more traditional diabetes self-management program, it also leaves many unanswered questions.  
The intervention was very intense, including various components (access to a library of diabetes-
related articles and websites, online advice, counseling and encouragement, tailored self-
management instruction, weekly chat/discussion groups, access to an Internet bulletin board, and 
the ability to submit daily glucose readings and other data to the study nurse).  This intervention 
also included substantially more interaction (among participants and between participants and 
the study nurse) than more traditional Internet-based therapies, making it difficult to determine 
the “active ingredient” in the intervention.  Another concern is the generalizabilty of these results 
to other elderly diabetics.  Participants were not required to have any computer experience prior 
to the study and Internet access and/or computers were provided to those who did not have 
access on their own.  They were also trained in the use of the computer if necessary.  It is also 
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not clear if an improvement in the psychosocial factors mediated the improvement in the 
physical factors (Bond et al., 2007). 
 Besides the Bond et al. (2007) study, only one other study of a psychosocial Internet 
intervention for patients with diabetes can be identified (van Bastelaar, Pouwer, Cuijpers, Riper, 
& Snoek, 2011).   This research aimed to decrease depression as well as diabetes-specific 
emotional distress.  The researchers hypothesized that these improvements would translate to 
improvements in diabetes self-management and glycemic control.   Depressed patients with type 
1 or type 2 diabetes were randomly assigned to an eight-week web-based course or a 12-week 
waiting list control group.  Participants logged into the study website once per week and received 
weekly emails from study coaches to remind them to log into the site, to encourage them to 
continue, and to provide feedback on homework assignments.  The Internet-based CCBT 
program included topics such as managing poor test results, blood glucose fluctuations, negative 
emotions, communication with health care professionals, talking about diabetes with others, the 
burden of diabetes self-management, and coping with diabetes-related worries.  Participants also 
had access to an Internet-based group forum moderated by study coaches, which allowed 
participants to share experiences, provide support, and discuss issues related to depression and 
diabetes. At the end of the intervention and at one month post-intervention, participants in the 
intervention group reported less diabetes-related distress and fewer depression symptoms.  
However, A1c did not significantly differ between the groups (van Bastelaar et al., 2011).     
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The Current Study   
 The current study tested the efficacy of a nine-week CCBT stress and mood management 
program in people with diabetes.  The program provided education about managing stress, 
preventing mood problems, and identifying and seeking treatment for anxiety and depression if 
necessary.  The program began with the stress management material, which is applicable to most 
adults.  It then presented CBT techniques for managing depression and anxiety.  The program 
ended with information on identifying when depression and anxiety require more intense 
treatment and explained treatment options.  The goal was that this program would provide 
diabetics with resources to manage stress.  In addition, given the high prevalence of anxiety and 
depression in this population, it is important to educate patients on ways to deal with these 
feelings, either on their own or with the help of a clinician.   
The primary goal of this study was to determine whether an online stress management 
intervention could reduce psychological distress in people with diabetes.  A secondary goal was 
to explore the antecedent model, which posits that psychological distress leads to poor glycemic 
control through its adverse effect on adherence.  Thus, the effects of the program on glycemic 
control, adherence, and other diabetes outcomes were also explored.  This research aimed to 
provide further insight into the ability of psychological distress reduction interventions to 
improve diabetes outcomes by improving adherence.  The following hypotheses were examined:   
1. CCBT-SM will lower psychological distress in the intervention group, compared to the 
control group. Perceived generalized stress, diabetes-related distress, symptoms of 
anxiety and depression, and mood will improve after participation in this program.   
2. Participation in CCBT-SM will result in improved glycemic control and fewer diabetes 
symptoms in the intervention group, compared to a waiting-list control group.  Due to 
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changes in the protocol during the study, this hypothesis became exploratory in nature 
(see below).   
3.  The mechanism through which CCBT-SM will improve diabetes outcomes is by 
lowering distress and improving mood.   Perceived generalized distress, diabetes-related 
distress, depression symptoms, anxiety symptoms, and mood will be examined as 
mediators of the ability of the CCBT-SM intervention to decrease diabetes symptoms and 
improve A1c.   
4.  Reducing psychological distress will improve adherence and adherence will mediate the 
effect of the intervention on diabetes outcomes.  
 During the course of the study some changes to were made to the methods to counteract 
difficulties with recruitment and retention of participants.  Obtaining A1c from medical records 
proved to be a large barrier to the participation of many patients, so this requirement was 
removed from the study.  Thus, the hypothesis related to the effect of the intervention on A1c 
(number 2 above) became exploratory. The number participants with valid A1c at pre- and post-
intervention did not provide enough power for adequate analyses.  In turn, the focus of the other 
hypotheses was shifted to other diabetes outcomes, specifically diabetes symptoms.   
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Figure 1.  The indirect effect of CCBT-SM on glycemic control via a reduction in psychological 
distress. 
  
Reduced	  	  
Psychological	  Distress	  
Improved	  	  
Glycemic	  Control	  
CCBT-­‐SM	  
	  
23 
 
 
 
 
 
 
 
 
Figure 2. The indirect effect of CCBT-SM on glycemic control via an increase in adherence. 
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Chapter Two: 
Methods 
The study protocol was approved by the Institutional Review Board at the University of 
South Florida. 
Participants 
Recruitment.  Recruitment was open to individuals in the United States.  Brochures and 
flyers were distributed to physicians, physician assistants, nurse practitioners, and diabetes 
educators nationwide via face-to-face meetings, email exchanges, and relevant newsletters and 
list servs.  The researcher explained the rationale and procedure of the study to the healthcare 
practitioners and asked them to distribute the literature to their patients with diabetes.  The 
literature included information about the study and directed interested individuals to the study 
website. 
Participants were also recruited via the Internet and email campaigns. Advertisements 
were placed on diabetes-relevant webpages and newsletters as well as on Facebook support 
pages. The research study was also listed on two clinical trial recruitment websites.  All 
advertising directed participants to the study website.   
 The study website outlined the purpose of the intervention and the requirements of 
participants.  The website included a link to the research summary/consent form.  Interested 
participants were asked to read the form and then complete an information sheet to enroll in the 
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study.  Participants were provided a phone number and email address to contact a researcher if 
they had any questions or concerns.  
 In addition to those who submitted an online enrollment form, a small number of 
participants were recruited using HealthStreet, a community engagement program operated by 
the University of Florida.  Individuals with type 2 diabetes who were registered with 
HealthStreet and indicated that they would be interested in research were contacted by 
HealthStreet personnel, given a brief description of the study and asked if they would be 
interested in participating.  The contact information for those who were interested was provided 
to the study researchers (n = 30).  The individuals were then contacted and provided with 
additional information about the study and screened to determine eligibility. 
Eligibility criteria.  Participants were required to be adults (over the age of 18).  Initially 
the study was limited to those who self-reported that they had been diagnosed with type 2 
diabetes.  However, due to low rates of recruitment, enrollment was opened to those who self-
reported that their doctor had diagnosed them with type 1 or type 2 diabetes.  
There were no psychological criteria for eligibility.  The intervention was designed to 
benefit the general population, so participants were not required to demonstrate feelings of stress, 
anxiety, or depression.  However, participants who endorsed suicidal ideation on the pre-
intervention questionnaire (n=5) were excluded from the study and encouraged to receive 
individual treatment.  Initially the study required that participants have a minimum A1c of 6.5, 
which is a typical cutoff for the diagnosis of diabetes.  However, this limited the number of 
interested individuals who were eligible to participate.  To improve recruitment, this requirement 
was lifted and there were no requirements regarding current diabetes management.   
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Participants were required to have access to a computer with an Internet connection.  It 
was also necessary for the computer to have the ability to play sounds via speakers or 
headphones.  The CCBT-SM program required the use of Adobe Reader and Macromedia Flash 
Player.  These programs were available for free download if they were not already installed.   
The study website used for advertising and recruitment tracked the number of visits to the 
site to provide an indication of the number of people who were curious about the study but 
decided not to enroll.  In addition, the researchers tracked the number of people who requested a 
telephone call but were ineligible to participate or who decided not to participate after receiving 
the telephone call.  
 Sample size.  The effect sizes that have resulted from similar studies suggest a moderate 
effect of stress management interventions on reducing psychological distress and A1c.  The 
Zetterqvist et al. (2003) online stress management intervention that was tested in healthy adults 
resulted in a medium effect size (d = 0.62) for the reduction in perceived stress.  However, this 
study included therapist contact and was highly structured, requiring the submission of 
homework assignments to be granted access to the next module.  It is not clear how this type of 
structure may affect the effect size.  A meta-analysis of non-Internet based work-related stress-
management programs indicated that interventions that used CBT (d = .68), relaxation (d = .35) 
and a combination of CBT and relaxation (d = .51) had an medium effect on post-test measures 
of stress (van der Klink et al., 2001).  Another meta-analysis of psychological distress 
interventions for people with diabetes found a medium effect size for stress management 
interventions (d = 0.43), but a small effect size (d = 0.18) for distress interventions in general 
(Bykowski, Sacco, & Mayhew, 2011).  The majority of this data suggest that a medium effect 
size could be expected.   
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An a priori power analysis using G*Power 3 (Faul, Erdfelder, Lang, & Buchner, 2007) 
indicated that with a total sample size of 107 participants, a multiple regression analysis would 
detect the effect of an intervention with the expected medium effect size (f2= .15) and α = .05.   
Previous studies of Internet-based treatments have experienced attrition rates that range from 
12% to 56%, with more recent studies having lower rates of attrition (Zetterqvist et al., 2003).  
Given this large range of attrition rates, this study planned for attrition that is between these 
extremes, approximately 34%.  Based on this data, the researchers planned to randomize at least 
142, approximately 71 participants in each group.  
At the completion of data collection, after consulting with members of the dissertation 
committee, it was decided that analysis of covariance (ANCOVA) would be a more appropriate 
statistical test of the proposed hypotheses.  An a priori power analysis using G*Power 3.1 (Faul, 
Erdfelder, Buchner, & Lang, 2009) indicated that a total sample size of 128 participants would 
be necessary for an ANCOVA to detect the effect of an intervention with the expected medium 
effect size (f = .25) and α = .05.  Given that the sample size was based on the original power 
analysis and the obtained sample was 108 participants, the ANCOVA analyses may be 
underpowered. 
Procedure 
The procedure for enrollment in the study was modified to improve recruitment and 
retention of participants.  Initially, individuals who visited the study website and were interested 
in participating in the study clicked on a link that directed them to an online form where they 
entered contact information.  Once the researchers received the information, the individual was 
contacted via telephone to review the study requirements and determine eligibility.  Individuals 
who were eligible and wished to participate were then mailed (via the US Postal Service) a 
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consent form and an authorization for the release of healthcare information form.  The release 
form stated that the participant allowed the release of their A1c levels by their physician to the 
researcher.  They were asked to complete and return the forms in a self-addressed stamped 
envelope. A copy of the consent form was kept on file and the release form was faxed to the 
participant’s physician at the beginning and end of their participation in the study. Once a valid 
A1c was obtained from the physician, the participant was sent a welcome email and link to the 
first questionnaire.  
This procedure faced several obstacles, including difficulties reaching participants by 
telephone, the amount of time lost waiting for the forms via the postal service, and requiring 
participants to complete forms and mail them back.  Thus, the procedure was streamlined. The 
link from the study website was amended to include an automated screening form.  Those who 
were eligible were then automatically directed to a study summary/consent sheet. A waiver of 
documentation of consent was obtained from the institutional review board because the study 
presented no more than minimal risk.  This allowed for consent to be acknowledged online 
immediately after individuals decided to participate.  Once the consent was read and 
acknowledged, eligible participants were directed to an online form to collect their contact 
information.  Completed forms were automatically sent to the researcher via email and the 
information was logged in a secure database. Once the researcher received the online contact 
form and acknowledgement of consent, the individual was mailed (via the US Postal Service) the 
release of information form and emailed a letter welcoming them to the study with a link to the 
first questionnaire. They were asked to complete and return the release form in a self-addressed 
stamped envelope. A copy was kept on file and faxed to the participant’s physician at the 
beginning and end of their participation in the study.  
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 The welcome email contained a link to the pre-intervention questionnaire (Q1), which 
was presented via Surveygizmo.com.  After participants completed the pre-intervention 
questionnaire, they were randomly assigned to the intervention or control group, via a random 
number generator.  Random assignment was initially 1:1 but after substantial attrition in the 
intervention group, it was changed to 2:1 (intervention : control) for the last third of the assigned 
participants.  If a participant indicated suicidal ideation on the pre-intervention questionnaires, 
they were excluded from the study and encouraged to seek individual psychotherapy from a 
mental health provider. The researcher provided referrals to national websites that aid in finding 
mental health services. 
 The treatment period and wait-list control period lasted nine weeks.  Following the fourth 
and ninth weeks, participants were sent an email and asked to complete the mid- and post-
intervention questionnaires (Q2 and Q3) via Surveygizmo.com.  Approximately two to three 
months after the participants completed the nine-week intervention (or waiting list) period, the 
researchers requested the most recent A1c from the participant’s physician.  At that point, the 
participants in the waiting list group were invited to participate in the intervention. 
 Initially participants did not receive compensation for their participation.  To improve 
recruitment, the protocol was revised so that the final two-thirds of participants were 
compensated for their time with gift cards to an online retailer.  They received a five-dollar gift 
card for each questionnaire completed and a bonus five-dollar gift card if they completed the 
entire study.  
Treatment Groups 
 CCBT-SM.  The intervention group participated in “Stress & Mood Management,” a 
web-based program designed to educate adults about managing stress, preventing mood 
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problems, and identifying and seeking treatment for anxiety and depression if necessary.  The 
program was centered on an interactive website that utilized graphics, animation, audio, and 
video to present the information in an engaging manner.   It used cognitive-behavioral techniques 
such as goal setting, problem-solving, identifying and challenging negative thoughts, relaxation, 
and time management.  The program was designed by researchers at the Center for Workforce 
Health and is available for employers to purchase and make available to their employees as part 
of a wellness program.  Users have access to the entire program and are encouraged to return to 
the program as necessary and to work through it at their own pace.  While this is the most 
convenient way to make the program available in a work-place setting, it tends to result in 
underutilization, making the program less effective.  The current study added structure to the 
program so that participants were encouraged to access it at least once each week and complete 
specific modules during each visit.  
Each participant in the intervention group received a unique username and password that 
was used to access the program and track use of the program and completion of tasks.  Each 
week participants received an email reminding them to complete a specified part of the program.  
They were told where to start and stop the program that week and were provided with a screen-
shot of the last screen they should see each week.  They were instructed to end the program when 
they arrive at that screen.  The email also included a link to a web-based questionnaire.  The 
questionnaire was referred to as a “self-check” that asked three multiple-choice questions about 
the week’s presentation, which were designed to help participants to remember the key points of 
the program.  They were provided with immediate feedback about the accuracy of their answers 
and provided with an explanation of the correct answer.  The “self check” also included an open-
ended question that asks them to indicate what information was most interesting, surprising, or 
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useful to them this week, to encourage participants to apply what they learned during the session 
to their lives. In addition to the “self-check” the questionnaire asked participants to use a 
checklist to indicate which, if any, stress management techniques were used over the previous 
week.  
The self-check was electronically submitted to the researchers once it was completed, 
which indicated that the participant had finished the program for the week.  If a participant did 
not submit their weekly self-check, they were sent an email to remind them to do so.  If they did 
not respond to the email, they were phoned by the researcher and sent another email.  The 
program also collected usage data to track the amount of time spent by each participant on each 
web-page; however these data were not available to the researchers until the end of the study. 
 The program was divided into eight modules.  Participants were instructed to allow at 
least 30 minutes to complete the modules, which were approximately 15 to 30 minutes long.  See 
Table 1 for a detailed description of the information covered in each lesson.  Each week the 
participants were given a homework assignment that was related to the week’s lesson.  
Assignments included self-monitoring stress responses, practicing relaxation techniques, and 
completing thought records (see Table 1 for specific information about each week’s homework 
assignment).   In some modules the assignment is specifically mentioned in the program.  
However, there are several modules that did not have an integrated homework assignment.  
Therefore, a homework assignment was created by the researcher to supplement these modules.   
The weekly reminder email always described the homework for the week.  The only contact with 
the researchers was through the weekly emails and reminder emails/telephone calls, which were 
standardized.  Researchers did not provide any additional therapy or counseling to the 
participants.  Appendix A includes the homework assignments created for this study. 
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 Waiting list control. The control group was put on a waiting list to participate in the 
study after a nine-week period.  These participants received an email halfway through the 
treatment period to provide a reminder of their participation in the study and ask them to 
complete the mid-intervention questionnaires (Q2).  They received another email after nine 
weeks asking them to complete the post-intervention questionnaire (Q3) and reminding them to 
provide another A1c measurement.  The control group was invited to participate in the 
intervention after they completed the post-intervention questionnaire. 
Measures 
 Participants completed each of the questionnaires described below at pre-, mid-, and post-
intervention (Q1, Q2, and Q3, respectively).  The demographic information was only collected 
pre-intervention, as the responses were not expected to change during the intervention.  A1c was 
collected only at pre- and post-intervention.  
 Perceived generalized stress.  The Perceived Stress Scale (PSS; Cohen, Kamarck, & 
Mermelstein, 1983) is a 14-item measure that assesses the degree to which respondents perceive 
situations in their lives as stressful.  Respondents used a Likert scale ranging from 0 (never) to 4 
(very often) to indicate how often they have experienced feelings of stress (e.g., “In the last 
month, how often have you felt nervous and stressed?” “In the last month, how often have you 
felt that things were going your way?”).  The score is obtained by reversing the scores on the 
seven positive items and summing across all items; a higher score indicates that the person 
perceives more stress.  The measure has been shown to have good internal consistency (α = .84 - 
.86) and test-retest reliability after two days (.85).  The internal consistency at baseline in the 
current study was slightly higher than previously reported (α = .90).  The PSS is correlated with 
number of life events (r = .17 to .39) and impact of life events (r = .24 to .49). The measure 
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predicts symptoms of depression and social anxiety as well as physical stress-related symptoms 
better than other commonly used life events scales (Cohen et al., 1983).  
 Diabetes-related distress.  The Problem Areas in Diabetes (PAID) Scale (Polonsky et 
al., 1995) was used to measure emotional distress associated with diabetes.  The scale consists of 
20 emotional problems that are often reported by people with diabetes.  The self-report measure 
asks respondents to indicate the degree to which each item is a problem for them using a Likert 
Scale that ranges from 0 (not at all) to 4 (serious problem).  The items address areas such as 
worry (“worrying about the future and possibility of serious complications”), anger (“feeling 
angry when you think about living with diabetes”), and interpersonal problems (“feeling that 
friends/family are not supportive of diabetes management efforts;” Polonsky et al., 1995).  The 
ratings are summed and multiplied by 1.25 so that the total score ranges from 0 to 100, with 
higher scores indicating more diabetes-related stress (Welch, Jacobson, & Polonsky, 1997).  The 
PAID has demonstrated high internal reliability (α = .95) and significant correlations with 
measures of general psychological distress (r = .63) and glycemic control (r = .30; Polonsky et 
al., 1995).  The internal consistency at baseline in the current study was also high (α = .94). 
 Affect.  Affect was assessed via the Positive and Negative Affect Schedule (PANAS; 
Watson, Clark, & Tellegen, 1988).  The 20-item scale consists of ten positive affect items (PA: 
attentive, interested, alert, excited, enthusiastic, inspired, proud, determine, strong, and active) 
and ten negative affect items (NA: distressed, upset, hostile, irritable, scared, afraid, shamed, 
guilty, nervous, and jittery).  Respondents are provided with a Likert scale ranging from 1 (very 
slightly or not at all) to 5 (extremely) and asked to indicate to what extent they have felt this way 
during the past few weeks.    The authors have demonstrated that the scale has good internal 
consistency (.87 for both NA and PA) and acceptable test-retest reliability after an 8-week period 
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(.58 for PA; .48 for NA).  It also has good convergent (.92 for both) and divergent validity (-.10 
for PA, -.18 for NA) as well as item validity (Watson et al., 1988).  The internal consistency at 
baseline in the current study was high for both positive affect (α = .91) and negative affect (α = 
.89). 
 Depression.  The presence and severity of depression symptoms was assessed via the 
nine-item depression measure from the Primary Care Evaluation of Mental Disorders Patient 
Health Questionnaire (PHQ-9).  The PHQ-9 is a brief measure of depressive symptoms that 
allows a health care provider to determine whether a primary care patient meets criteria for 
Major Depressive Disorder (MDD) and also offers a measure of severity of symptoms.  The 
scale consists of the nine DSM-IV criteria for MDD and respondents are asked to indicate 
whether they experience each symptom “not at all,” “several days,” “more than half the days,” or 
“nearly every day.” These responses are scored 0, 1, 2, 3, respectively and summed.  Scores from 
5 - 10 indicate mild depression, 11 - 15 indicate moderate depression, 16 – 20 indicate 
moderately severe depression and above 20 indicate severe depression.  Respondents who 
indicate that they experience five symptoms more than half the days or nearly every day, with 
one of the symptoms being “little interest or pleasure in doing things” or “feeling down, 
depressed, or hopeless” are designated as meeting criteria for MDD.  Criteria for suicidal 
ideation are met if respondents indicate any presence of “thoughts that you would be better off 
dead, or of hurting yourself in some way.”  The PHQ-9 has been shown to have high internal 
consistency (α = .86 - .89) and test-retest reliability (.84) and has shown to be a sensitive and 
specific diagnostic tool that is highly correlated with diagnoses made by mental health 
professionals as well as with indices of functional impairment (.33 - .73) and health care 
utilization (.24 - .55; Kroenke, Spitzer, & Williams, 2001; Spitzer, Kroenke, Williams, & The 
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Patient Health Questionnaire Primary Care Study Group, 1999).  There was high internal 
consistency at baseline in the current study (α = .87). 
Anxiety.  The presence and severity of symptoms of generalized anxiety disorder were 
assessed via the GAD-7 (Spitzer, Kroenke, Williams, & Lowe, 2006).  This seven-item scale 
asks respondents to indicate how often over the previous 2 weeks they experienced each of seven 
symptoms of anxiety (e.g., “feeling nervous, anxious, or on edge,” “being so restless that is hard 
to sit still”).  Respondents respond to each symptom “not at all,” “several days,” “more than half 
the days,” or “nearly every day.”  The responses are scored from 0 to 3 and summed, resulting in 
a total score that ranges from 0 to 21, with high scores indicating high levels of anxiety.  A score 
greater than 10 suggests a diagnosis of Generalized Anxiety Disorder.  Scores from 6 – 10 
indicate mild anxiety, 11 – 15 indicate moderate anxiety and scores greater than 15 indicate 
severe levels of anxiety.  The scale has been shown to have good internal consistency (Cronbach 
α = .92) and test-retest reliability (.83).  The scale is significantly correlated with functional 
impairment (.30 - .75) and symptom-related difficulty (.63).  It is also highly correlated with the 
Beck Anxiety Inventory (r = .72) and the anxiety subscale of the Symptom Checklist-90 (r = .74) 
and independent diagnoses of anxiety made by mental health professionals conducting a clinical 
interview (Spitzer et al., 2006).  There was high internal consistency at baseline in the current 
study (α = .90). 
Adherence.  The degree to which the participants were engaging in activities to manage 
their diabetes was measured via the revised version of the Summary of Diabetes Self-Care 
Activities (SDSCA; Toobert, Hampson, & Glasgow, 2000).  The SDSCA is a multi-dimensional 
measure that consists of 11 core items that assess diet, exercise, blood sugar testing, foot care, 
and smoking over the previous seven days.  Fourteen additional questions provide further 
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information about self-care recommendations, diet, medications, foot care, and smoking.  In a 
summary of seven studies that used the scale, the inter-item correlations for the core items were 
generally acceptable (mean = .47).  A moderate level of test-retest reliability over a three to four 
month period was also demonstrated (mean r = .40).  The dietary and exercise sub-scales were 
also significantly correlated to other measures of compliance to dietary (e.g., food records, Food 
Habits Questionnaire) and exercise (e.g., Physical Activity Scale for the Elderly, Stanford 7-Day 
Recall) recommendations.  The 14 additional items were recently added to provide more 
information to clinicians and researchers but there is no data regarding the reliability and validity 
of these items (Toobert et al., 2000).  The internal consistency at baseline in the current study 
was high for the general diet (α = .93), exercise (α = .91), blood glucose testing (α = .85) but low 
for foot care (α = .54) and specific diet subscales (α = .36). 
Diabetes symptoms. The Diabetes Symptom Checklist-Revised (DSC-R; Arbuckle et al., 
2009) assessed the number and severity of diabetes-related symptoms that the participants are 
experiencing.  This scale was initially developed as a tool for clinicians to assess symptoms and 
track changes due to treatment.  The 34-item scale assesses hyperglycemic (e.g., thirst, dry 
mouth), hypoglycemic (e.g., moodiness, irritability), psychological-cognitive (e.g., sleepiness, 
difficulty concentrating), psychological-fatigue (e.g., lack of energy, overall sense of fatigue), 
cardiovascular (e.g., shortness of breath, palpitations), neurological-pain (e.g., pain in the legs 
and calves), neurological-sensory (e.g., numbness in hands and feet), and ophthalmologic (e.g., 
blurred vision, deteriorating vision) symptoms.  Participants are asked whether they have 
experienced each symptom in the past 4 weeks.  If they have experienced a particular symptom, 
they are asked to indicate how troublesome the symptoms is, using a 5-point Likert scale (1 = not 
at all; 5 = extremely).   Responses are summed to obtain an overall score as well as sub-test 
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scores for each domain, with higher scores indicating more diabetes symptom burden.  Subtest 
scores are divided by the number of items in the domain to allow for comparison of scores across 
domains.  All subscales have been shown to have good internal consistency (Cronbach α = .69 - 
.87; Arbuckle et al., 2009).  The internal consistency at baseline in the current study was high for 
total score (α = .94) as well as the subscales (α = .69 - .87).  The DSC-R subscales have small to 
moderate correlations with SF-36 scores of perceived health status (-.22 to -.69). Higher DSC-R 
scores are associated with higher A1c and higher BMI.  Further, changes in DSC-R scores after 
one year were consistent with patients’ reports of perceived health changes (Arbuckle et al., 
2009).   
Glycemic control.  Glycemic control was assessed via hemoglobin A1c, an index of 
glucose regulation over a period of about two to three months (Lustman, Griffith, Freedland, & 
Clouse, 1997b).  A high A1c level is indicative of poor glycemic control.  It is generally 
recommended that A1c be as low as possible without causing hypoglycemic complications; for 
most diabetics this is less than 7% ("Executive summary: Standards of medical care in diabetes--
2009," 2009; Qaseem et al., 2007).   
A1c was obtained from the participants’ medical records.  Participants were asked to sign 
a release of information form when they enrolled in the study.  The researcher forwarded the 
release form to participant's physician and the physician was asked to provide the researcher with 
the patient’s A1c values within a specified time period.  Initial A1c was valid if measured no 
more than 90 days before completing Q1 or no more than 30 days after completing Q1.  Final 
A1c was valid if measured no more than 30 days before completing Q3 or no more than 90 days 
after completing Q3.  These time periods reflect the characteristic of A1c as a weighted average 
of glucose control over the past 90 -120 days, with the most recent 30 days having a greater 
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effect on the measurement.  Thus, these periods are assumed to give the best approximation of 
A1c before and after the intervention period.  
Demographic information and treatment history.  Participants were asked to complete 
a survey that was designed for this study.  Questions included demographic information such as 
age, race, gender, education, and marital status.  They were also asked about their diabetes 
history, such as how long since diagnosis, what they are doing to control their diabetes (e.g., diet, 
medication, insulin, etc), and their overall sense of their ability to manage diabetes.  Participants 
were asked to indicate whether they have ever sought psychological counseling or medication, 
whether they are currently receiving counseling or medication, and whether they would consider 
seeking services in the future if they thought it was necessary.  
Data Analysis 
Preliminary analyses. The characteristics of the participants in the intervention and 
control groups were compared to determine whether random assignment was successful.  T-tests 
and χ2 analyses were conducted to determine whether the groups significantly differed on 
demographic and diabetes-specific characteristics (number of males/females, ethnic proportions, 
age of participants, length of time since diabetes diagnosis, etc.). Those who completed the study 
and those who withdrew were also compared to determine the effect of attrition on the sample.  
Outcome analyses. The efficacy of CCBT-SM was tested using Analysis of Covariance 
(ANCOVA).  Pre-study (Q1) scores on the outcome measures (PSS, PAID, PHQ-9, GAD-7, 
PANAS, A1c, DSC-R, and SDSCA) were entered into the model as covariates with intervention 
group as the fixed factor and post-study (Q3) scores as the dependent variable.  The significance 
of the F-value for group was used to determine whether the intervention significantly influenced 
the Q3 scores, controlling for the Q1 scores.  
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The data for the mid-study questionnaire (Q2) were not used in the outcome analyses.  
This questionnaire was administered halfway through the intervention/waiting period to 
potentially counteract the effect of attrition.  The data was to be used to increase the power of the 
study if there was substantial attrition after the halfway point.  However, including the 
questionnaire only allowed for the inclusion of data from five participants in the intervention 
group.  In the control group there fewer people who completed Q2 than Q3.  Because the data in 
the middle of the intervention does not speak to the efficacy of the entire intervention and it did 
not significantly increase the sample size, it was decided to not include it in the final analyses. 
Mediation analyses.  It was hypothesized that there would be an indirect effect of the 
intervention on glycemic control and diabetes symptoms through a reduction in psychological 
distress (see Figure 1) and there would be an indirect effect of the intervention on diabetes 
symptoms through an increase in adherence (see Figure 2). The Bootstrapping Method was used 
to test these hypotheses, employing the SPSS macro provided by Hayes (2013).  This method 
provides an estimate of indirect effect that makes no assumption about the shape of the 
distribution of the indirect effect.  The bias-corrected bootstrapped 95% confidence interval 
(BCa CI) is estimated using 1000 bootstrapped samples.  The indirect effect is determined to be 
significant if the BCa CI around the estimate does not include 0.  The mediation effect size was 
measured using the ratio of the indirect effect to the total effect (PM), which is loosely interpreted 
as the proportion of the total effect that is mediated.  This is one of the most widely used effect 
sizes for mediation (Preacher & Kelley, 2011).  
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Table 1 
Outline of the CCBT-SM Intervention	  	  
Week  /  Time Topics Covered Homework 
Week 1 
 
16 – 20 
minutes 
Overview 
• How to use this Program (1:11) 
• About this Program (1:35) 
Stress Management  
• Introduction (1:36) 
• Assess Your Stress (0:17) 
o Self-Assessment 
• The Stress Response  
o This Thing Called stress (0:39) 
o Primitive vs. Modern (1:23) 
o Fight or Flight (1:12) 
o A Vicious Cycle (1:15) 
o What Next? (1:17) 
• Identify Stressors 
o Introduction (1:40) 
o Stress Symptoms  (0:45) 
o Recognize Symptoms (0:23) 
o Personal Stressors (1:51) 
Identify Your 
Personal Stressors 
Worksheet 
(original) 
Week 2 
 
10 
minutes 
Avoid Negative Coping 
• The Trap (1:22) 
• Alcohol – A Legal Drug (1:16) 
• The Drug Trap (1:22) 
• Self-Assessment (0:16) 
• Positive Alternatives (0:55) 
• Tips for Cutting Down (1:00) 
• Managing Social Drinking (0:59) 
• A Healthy Lifestyle (0:35) 
Identify Your 
Personal Stressors 
(original)  
& Negative 
Coping Worksheet 
(additional) 
Week 3 
 
 16 – 20 
minutes 
Make Positive Choices 
• Introduction (1:19) 
• Adopt Mental Strategies (1:02) 
o The Mental Lens (1:27) 
o Choosing Optimism (1:34) 
o Optimism vs. Pessimism (2:55) 
o Avoid Negative Thinking (1:46) 
o Changing Negative Thinking (1:20) 
o Embrace Positive Thinking (1:36) 
o Finding Humor (1:17) 
o Stress Hardiness (1:24) 
Embrace Positive 
Thinking 
Worksheet 
(additional) 
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Table 1 (continued) 
 
Week  /  Time Topics Covered Homework 
Week 4 
 
10  
minutes 
Make Positive Choices 
• Adopt Behavioral Strategies (0:16) 
o Physical Activity (1:41) 
o Stress Emergencies (0:52) 
o Relaxation Practice (0:32) 
o Breathwork (1:12) 
o Progressive Relaxation (1:03) 
o Guided Imagery (1:25) 
o Meditation (1:23) 
Practice the 
relaxation 
exercises (mp3s) 
(original) 
 
Use worksheet to 
track effect of 
relaxation on 
tension  
(additional) 
Week 5 Mid-Intervention Questionnaire 
 
Continue to 
practice the 
procedures learned 
over the past 4 
weeks; use 
worksheets that 
were most useful 
Week 6 
 
15  
minutes 
Make Positive Choice 
• Adopt Behavioral Strategies 
o Social Support (1:44) 
o Time Management (2:42) 
• Take Charge (Assertiveness & Problem-Solving) 
o Introduction (2:20) 
o Take Charge at Work (2:09) 
o Take Chare at Home (1:23) 
o Take Charge Against Terrorism (1:30) 
o Go For It – Review of stress management (1:48) 
Problem solving 
Worksheet 
(additional) 
Week 7 
 
25 - 30 
minutes 
Managing Depression 
• Introduction (0:57) 
• Are You Feeling Depressed (0:48) 
o Assess Yourself (0:14) 
• The Nature of Depression 
o Major Depressive Disorder (1:11) 
o Dysthymia (0:37) 
o Bipolar Disorder (1:09) 
• The Impact of Depression  
o Introduction (0:41) 
o Emotions and Moods (0:46) 
o Thinking (0:49) 
o Physical Functioning (0:52) 
o Behaviors (0:49) 
Download the  
Thought Record 
(original) 
 
and/or 
 
Lists Worksheet 
(additional) 
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Table 1 (continued) 
 
Week  /  Time Topics Covered Homework 
Week 7 
(Continued) 
• Managing Your Mood 
o Introduction (1:49) 
o Get Your Mind Right (0:28) 
§ Mental Lens (1:11) 
§ Harmful Thinking (1:12) 
§ Identify Harmful Thinking (0:47) 
§ 3 Types of Harmful Thinking (1:03) 
§ Choosing Optimism (1:47) 
§ Optimism vs. Pessimism (2:55) 
§ Challenging Harmful Thinking (0:56) 
§ Embracing Positive Thinking (0:47) 
o Get Your Body Right – exercise, sleep (1:01) 
o Get Your Actions Right – activity schedule (0:56) 
o Connecting with Others (0:55) 
The Time is Now (0:51) 
 
Week 8  
 
35  
minutes 
Managing Anxiety  
• Introduction (1:01) 
• What is Anxiety  
o Introduction (0:51) 
o Crossing the Line (1:13) 
o Assess Yourself (0:20) 
• Types of Anxiety Disorders  
o Introduction (1:14) 
o Specific Phobia (1:12) 
o Social Phobia (1:09) 
o Panic Disorder (1:21) 
o Generalized Anxiety Disorder (1:11) 
o Obsessive-Compulsive Disorder (1:14) 
o Post-Traumatic Stress Disorder (1:19) 
• Strategies that Work  
o Introduction (1:33) 
o Getting Your Body Right (0:42) 
§ Deep Relaxation (0:49) 
§ Breathing (1:16) 
§ Progressive Muscle Relaxation (1:13) 
§ Guided Imagery (1:04) 
§ Meditation (1:43) 
§ Regular Physical Activity (1:00) 
§ Eat Smart (1:24) 
§ See Your Physician (0:41) 
o Get Your Mind Right (1:28)  
§ Threatening Thoughts (1:19) 
§ Identifying Threatening Thoughts (0:48) 
§ Challenging Threatening Thoughts (0:57) 
Thought Record 
for Challenging 
Threatening 
Thoughts 
(additional) 
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Table 1 (continued) 
 
Week  /  Time Topics Covered Homework 
Week 8 
(continued) 
o Get Your Actions Right (0:46) 
§ Expressive Writing (1:04) 
§ Overcoming Procrastination (1:08) 
§ Facing Your Fears (1:14) 
§ One Step at a Time (1:29) 
 
Week 9 
 
25 – 30 
minutes 
Treatments that Work  
• Introduction (1:06) 
• Where to Start 
o Overcoming Stigma (1:17) 
o Evaluation and Diagnosis (1:08) 
• Psychotherapy  
o Introduction (2:35) 
o Picking the Right Person (1:05) 
o Other Important Factors (1:08) 
o Cognitive Behavior Therapy (1:15) 
o CBT for Depression (1:09) 
o CBT for Anxiety (1:32) 
o Interpersonal Psychotherapy (0:51) 
o IPT for Depression and Anxiety (0:52) 
o Psychodynamic Therapy (1:00) 
o PDT for Depression and Anxiety (1:14) 
• Medications  
o Introduction (1:06) 
o Questions to Ask (0:59) 
o Classes of Medications (0:44) 
o How They Work (1:13) 
o  SSRIs (1:22) 
o Side Effects of SSRIs (0:58) 
o Anti-anxiety Medications (1:22) 
o Mood Stabilizers (1:03) 
• Fit is Key 
o Do You Feel Comfortable? (1:06) 
Resources  
No official 
homework.  
Participants were 
encouraged to 
continue to use 
the skills they 
have been 
learning 
throughout the 
program.  They 
were told that 
this is the last 
week that they 
have access to 
the program and 
that they are free 
to review the 
program as 
needed over the 
course of the 
week. 
Note. The outline above contains all of the sections that comprise the CCBT-SM intervention.  
The length of each module is in parentheses following the title of the section.  The sections have 
been divided to create 8 modules.  The homework section indicates whether the assignment was 
part of the original program (original) or whether it was created for use with this more structured 
version of the original program (additional).  The additional homework worksheets can be found 
in Appendix A.  
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Chapter Three 
Results 
Recruitment 
All advertisements and literature related to the study directed interested individuals to the 
study website.  The website received 4949 visits from unique IP addresses.  From those visits, 
608 individuals expressed interest in the study by completing an enrollment form with their 
contact information.  An additional 30 individuals were recruited directly from HealthStreet.   
Of the 638 enrollment forms that were submitted, 6 were determined to be falsified (i.e., 
the phone numbers and addresses were not valid) and 103 individuals could not be reached after 
several attempts via email and telephone.  Of those who were assessed for eligibility (n = 529), 
352 were excluded because they did not meet eligibility criteria, did not complete the screening 
process, or declined to participate.  The remainder (n = 177) were randomly assigned to the 
intervention or control group.  See Figure 3 for additional information regarding recruitment and 
attrition. 
As expected, the attrition rate was high.  Due to 39% of participants not completing the 
final questionnaire, a higher number of participants than expected were randomized (N = 177). 
Also, the rate of attrition was higher for the intervention group (44%) compared to the control 
group (20%).  To allow for better comparisons, randomization for the last third of the study was 
done at a 2:1 ratio, with twice as many participants randomly assigned to the to the intervention 
group (n = 103) compared to the control group (n = 74). 
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Sample Characteristics 
The baseline characteristics of the sample are outlined in Table 2.  Participants were 
recruited from 40 states across the US, with the highest percentage (18.6%) from Florida.  
Participants were primarily women and Caucasian.  They ranged in age from 19 to 83 (M = 
55.13, SD = 13.9).  All but one participant graduated from high school, with more than half 
achieving a college degree or higher (58.7%).   
Approximately two-thirds of the sample reported that they had been diagnosed with type 
2 diabetes (66 %) and on average the sample had been living with diabetes for 15.41 years (SD = 
12.7).  The majority reported they considered their diabetes management to be fair (35.6%) or 
good (37.3%).   Most (89.8%) reported at least one chronic illness other than diabetes.   
Slightly more than half of the participants reported that they had undergone some type of 
psychotherapy (55.9%) and/or taken a psychotropic medication (53.7%) at some point in their 
lives.  However, only about one-third (33.9%) were currently taking a psychotropic medication.  
The sample’s mean score on the PHQ-9 (M = 9.08, SD = 5.6) indicates a mild level of 
depression, with scores ranging from 0 (no depression) to 26 (severe depression).  Similarly, the 
scores on the GAD-7 indicate a mild to moderate level of anxiety (M = 7.92, SD = 5.2) with a 
range of 0 (no anxiety) to 21 (severe anxiety).   There are no published cut-offs for the PSS. 
Possible scores range from 0 to 56.  The range in the current sample was from 8 to 49 and the 
mean was 29.23 (SD = 8.0).  The amount of diabetes-related distress reported in the sample (M = 
46.86, SD = 24.4) indicated high levels of distress.  
Preliminary Analyses 
Statistical comparisons indicated that randomization was successful (see Table 2).  There 
were no significant differences between the intervention and waiting list group on baseline 
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demographic, diabetes, or psychological characteristics.  With the exception of blood glucose 
testing, this was also the case when comparing only those who completed the study (see Table 
3).   Those who completed the study in the intervention group reported more frequent blood 
glucose testing than those who completed the study in the waiting list group.  
 Table 4 provides comparisons between those who completed the study and those who did not.  
While those who did not complete the study did not differ from those who did on demographic 
characteristics, there were some differences in other areas.  Those who did not complete the study were 
more likely to describe their diabetes management as “poor.”  They also reported higher levels of 
negative affect and anxiety.   
  Correlations of A1c with the outcome variables are shown in Table 5.  There were no 
correlations between reported severity of total diabetes symptoms and A1c.  However, A1c was 
correlated with ophthalmological symptoms (at baseline) and sensory symptoms (at final 
assessment).   There were also almost no correlations between A1c and the psychological 
measures.  The one exception is a positive relationship between A1c and diabetes-related distress 
at baseline (see Table 5).   A1c at baseline was also related to adherence to general diet 
recommendations.   
 Correlations of psychological outcomes with diabetes outcomes and adherence at 
baseline are shown in Tables 6 and 7.  Correlations of psychological variables with diabetes 
symptoms were significant at baseline (Table 6) and at the end of the intervention (Table 7).  
However, there were few significant relationships between the psychological variables and 
adherence variables. A notable exception is the positive correlations of positive affect with 
adherence to diet and exercise recommendations (see Tables 6 and 7).   
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CCBT-SM Utilization 
 The use of CCBT-SM by those in the intervention group was measured in multiple ways.  
The primary assessment of program engagement was through the weekly “self-checks.”  These 
short quizzes were sent to the participants each week in the weekly program email.  When the 
self-check was complete, the researcher received a notification email.   Participants who did not 
complete the self-check in a timely manner were reminded to access the program and complete 
the self-check (see methods section for further detail).  On average participants completed 7.39 
(SD = 1.2) weekly self-checks and the majority (67.3%) completed all eight.   
 The program website also contained software that provided information on overall 
utilization of the program by each participant at the conclusion of the study. On average, 
participants logged-in to the program 11.8 (SD = 6.0) times, visited 100 (SD = 34.4) of the 
program’s 124 pages, and spent 335 (SD = 236.3) minutes in the program. These numbers are 
higher than what was expected (i.e., log-ins once per week, total of 140 minutes spent on the 
program). 
Tests of ANCOVA Assumptions 
The assumptions of ANCOVA were examined.  Visual inspection of scatterplots and 
significant correlations (see Appendix B) indicated linear relationships between all Q1 and Q3 
measures for each group.   Standardized residuals for the group were not normally distributed for 
several of the variables (Shapiro-Wilk’s test p >.05) including negative affect, generalized 
anxiety, and depression.  Transforming the variables resulted in normal distributions but did not 
change the outcome of the ANCOVAs, thus the untransformed data is reported below.  The 
distributions of standardized residuals were also non-normal (Shapiro-Wilk’s test p >.05) for 
several of the diabetes symptom clusters (neurological pain, sensory, cardiac, and 
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ophthalmological symptoms).  Inspection of the data revealed that most participants reported 
very few or no symptoms in these clusters. The distribution of standardized residuals for 
adherence to blood-glucose testing recommendations was also non-normal.  Multiple 
transformations of these data were performed but normality was unable to be achieved.  
Although ANCOVA is robust to non-normality of distributions, these analyses should be 
interpreted with caution. In addition, the distribution of standardized residuals for adherence to 
foot care recommendations was positively skewed.  There was one obvious outlier in the data of 
the intervention group.  When this value was removed, a normal distribution was achieved.  
However, the results of the ANCOVA were unchanged.  The data-point was determined to be 
valid, thus this participant’s data remained in the dataset.   
 Equality of error variances was significant for positive affect, anxiety, and hypoglycemia 
(Levene’s test of equality of error variances p <. .05).   In all cases transforming the data 
achieved homogeneity of variances but the results of the ANCOVA were not affected. Visual 
inspection of scatter plots of standardized residuals against predicted values raised some 
concerns of heteroscedasticity.  However, in all cases, transforming the dependent variable 
achieved homoscedasticity but did not affect the outcome of the ANCOVA.  Thus, the 
untransformed data are reported below.   
Hypothesis 1: Effect of CCBT-SM on Psychological Distress 
The first hypothesis stated that CCBT-SM would lower psychological distress in the 
intervention group, compared to the control group. Perceived generalized stress, diabetes-related 
distress, symptoms of anxiety and depression, and mood were expected to improve after 
participation in CCBT-SM.  ANCOVAs were used to examine to this hypothesis. 
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 This hypothesis was supported (see Table 8).   Group assignment had a significant effect 
on all measures of psychological distress (i.e., perceived generalized stress, diabetes-related 
distress, symptoms of anxiety and depression, and negative affect) at post-intervention when 
controlling for baseline scores, with the intervention group scoring lower than the control group 
on all of these measures. There was a medium effect size for diabetes-related distress, anxiety, 
depression, and negative affect and a large effect for perceived generalized distress.  The 
intervention did not have a significant effect on positive affect. 
 The ANCOVA testing the effect of the intervention on negative affect must be qualified 
due to heterogeneity of slopes in this model.  That is, the group*covariate (negative affect at Q1) 
interaction was significant (F(1,102) = 6.54, p = .012).  Examination of plots of the regression 
lines (see Figure 4) demonstrated that the treatment effect varied across levels of baseline 
negative affect.  Those who started with a low level of negative affect did not benefit from the 
intervention.  However, in those with higher baseline negative affect, the group placement had a 
greater affect on Q3 negative affect scores.    
Hypothesis 2:  Effect of CCBT-SM on Diabetes Symptoms and Glycemic Control 
 The second hypothesis stated that participation in CCBT-SM would result in improved 
glycemic control and fewer diabetes symptoms in the intervention group compared to a waiting-
list control group.   ANCOVAs were also used to test this hypothesis (see Table 9).  
 The ANCOVA did not indicate a significant effect of intervention on A1c.  However, due 
to a change in the methods, only 46 participants (less than half of the sample) submitted valid 
post-intervention A1c results.  Thus, this analysis was underpowered.   
 There was also no effect of intervention on the total severity of diabetes symptoms.  
However, there were some effects on symptom clusters (see Table 9).  The intervention had 
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significant effects on psychological fatigue, cognitive symptoms, hyperglycemic symptoms, and 
hypoglycemic symptoms.  There were large effect sizes for cognitive symptoms and symptoms 
of hypoglycemia and small effect sizes for psychological fatigue and symptoms of 
hyperglycemia.  In each instance, the intervention group scored lower on these measures than the 
control group.  
 The ANCOVA testing the effect of the intervention on hyperglycemic symptoms must be 
qualified due to heterogeneity of slopes in this model.  That is, the group*covariate 
(hyperglycemic symptoms at Q1) interaction was significant (F (1,94) = 9.92, p < .01).    
Examination of plots of the regression lines (see Figure 5) demonstrated that the treatment effect 
varied across levels of baseline hyperglycemic symptoms.  Those who started with a fewer 
hypoglycemic symptoms did not benefit from the intervention.  However, in those with more 
baseline hyperglycemic symptoms, the group placement had a greater affect on Q3 
hyperglycemic symptoms.   
Hypothesis 3: Psychological Distress will Mediate the Effect of CCBT-SM on Symptoms 
 The third hypothesis stated that the mechanism through which CCBT-SM will improve 
diabetes outcomes is by lowering distress and improving mood.   Because there was not a 
significant effect of the intervention on A1c, a mediation analysis was not performed for this 
variable.  However, there were significant intervention effects for the symptom clusters of 
fatigue, cognitive symptoms, hypoglycemic symptoms and hyperglycemic symptoms.  Thus, 
perceived generalized distress, diabetes-related distress, depression symptoms, anxiety 
symptoms, and negative affect were examined as mediators of the ability of CCBT-SM to 
decrease these symptoms.   
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 There were significant indirect effects of the intervention on fatigue, cognitive symptoms, 
hypoglycemic symptoms, and hyperglycemic symptoms through all of the psychological distress 
measures (see Figure 6 and tables 10-13).   Examination of the effect sizes indicates that 
depression and perceived generalized stress have the largest influence on the relationship 
between the intervention and diabetes outcomes.   
 Because these mediation analyses were conducted with data from the same time (Q3), 
directionality cannot be inferred.  That is, it is possible that rather than there being an indirect 
effect of CCBT-SM on diabetes symptoms through psychological distress (see Figure 6), there is 
an indirect effect of CCBT-SM on psychological distress through diabetes symptoms (see Figure 
7).  To better understand these competing models, additional mediation analyses were conducted 
to compare the size of the indirect effect in each pathway.  As can be seen in Tables 14 -17, the 
reversed models tend to show weaker indirect effects (i.e., the completely standardized indirect 
effects and effect sizes are smaller).  These analyses offer the best support for a path from 
CCBT-SM to psychological distress to fatigue and hyperglycemic symptoms.  When the first 
model is reversed (that is, the path becomes CCBT-SM to fatigue to psychological distress), all 
indirect effects are smaller and those with depression and anxiety as outcomes are not significant 
(see Tables 10 and 14).  Similarly, when the path from CCBT-SM to psychological distress to 
hyperglycemic symptoms is reversed, all indirect effects are smaller and the indirect effects on 
perceived generalized distress and diabetes-related distress are not significant (see Tables 12 and 
16). The pathway from CCBT-SM to psychological distress to hypoglycemic symptoms was 
among the weakest of those tested.   When the pathway is changed to CCBT-SM to 
hypoglycemic symptoms to psychological distress, the indirect effects are not greatly affected.  
In the case of anxiety, the size of the indirect effect of hypoglycemic symptoms actually slightly 
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increases (see Tables 13 and 17).  Therefore, it is not clear whether the psychological distress 
variables mediate the effect of the intervention on hypoglycemic symptoms or if hypoglycemic 
symptoms mediate the effect of the intervention on psychological distress.   
Hypothesis 4: Adherence will Mediate the Effect of CCBT-SM on Diabetes Outcomes.  
 The fourth hypothesis posited that there would be an indirect effect of CCBT-SM on 
diabetes outcomes through adherence to diabetes management recommendations. There were no 
significant effects of the intervention on adherence to the diabetes treatment regimen (see Table 
18).  That is, the intervention did not have a significant effect on adherence to diet, exercise, 
blood-glucose testing, or foot care recommendations.  Therefore, this hypothesis was not tested.   
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Table 2 
Baseline Characteristics of Participants Randomized to the Computerized Cognitive-Behavioral Therapy for Stress Management 
(CCBT-SM) or the Waiting List Group 
  Total Sample CCBT-SM 
Waiting 
List   
  (N = 177) (n = 103) (n = 74)   
Demographic Variables     
Age in years 55.13 (13.9) 55.22 (13.3) 54.99 (14.6) t (174) = .11, p >.05 
Women 130 (73.4) 76 (73.8) 54 (74.0) X2 (1) = .001, p > .05 
Caucasian 155 (87.6) 92 (89.3) 69 (93.2) X2 (1) = .806, p > .05 
Married 106 (59.9) 60 (58.3) 46 (62.2) X2 (1) = .274, p > .05 
College graduate or higher 104 (58.7) 56 (54.4) 48 (66.7) X2 (1) = 1.96, p > .05 
Diabetes-Related Variables     
Type 2 117 (66.1) 65 (63.1) 52 (70.3) X2 (1) = .986, p >.05 
Years since Diagnosis 15.41 (12.7) 15.9 (13.8) 14.72 (10.9) t (164) = .587, p >.05 
Hemoglobin A1c 7.60 (1.3) 7.59 (1.1) 7.61 (1.6) t (79) = -.041 p >.05 
Diabetes symptoms (Total) 39.25 (28.4) 39.98 (28.8) 38.23(28.1) t (175) = .403, p >.05 
       Sensory 0.91 (1.13) 1.01 (1.2) 0.76 (1.0) t (169) = 1.44, p >.05 
       Psychological Fatigue 2.21 (1.36) 2.19 (1.3) 2.24 (1.4) t (169) = -.217, p >.05 
       Cognitive 1.69 (1.36) 1.71 (1.3) 1.67 (1.3) t (168) = .202, p >.05 
       Neurological Pain 0.57 (1.0) 0.61 (1.0) 0.51 (1.1) t (165) = .628, p >.05 
       Cardiac 0.75 (0.9) 0.78 (1.0) 0.72 (0.9) t (171) = .408, p >.05 
       Ophthalmologic 0.62 (1.0) 0.60 (0.9) 0.63 (1.1) t (168) = -.210, p >.05 
       Hypoglycemic 1.67 (1.2) 1.66 (1.27) 1.67 (1.2) t (171) = -.052, p >.05 
       Hyperglycemic 1.29 (1.2) 1.33 (1.3) 1.24 (1.2) t (165) = .474, p >.05 
Ability to Manage Diabetes     
       Horrible 6 (3.4) 4 (3.9) 2 (2.7) X2 (1) = .183, p >.05 
       Poor 24 (13.6) 15 (14.6) 9 (12.2) X2 (1) = .212, p >.05 
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  Total Sample CCBT-SM 
Waiting 
List   
  (N = 177) (n = 103) (n = 74)   
     
       Fair 63 (35.6) 39 (37.9) 24 (32.4) X2 (1) = .554, p >.05 
       Good 66 (37.3) 37 (35.9) 29 (39.2) X2 (1) = .197, p >.05 
       Excellent 15 (8.5) 8 (7.8) 7 (9.5) X2 (1) = .159, p >.05 
Oral Diabetes Medication 108 (61.0) 62 (60.2) 46 (62.2) X2 (1) = .070, p >.05 
Insulin 106 (59.9) 62 (60.2) 44 (59.5) X2 (1) = .010, p >.05 
Chronic Illnesses 3.97 (2.9) 4.19 (2.9) 3.66 (2.7) t (175) = .12, p >.05 
Adherence to Diabetes Regimen    
General diet 4.38 (1.8) 4.37 (1.9) 4.42 (1.7) t (173) = -.171, p >.05 
Specific diet 3.84 (1.6) 3.85 (1.7) 3.81 (1.5) t (172) = .141, p >.05 
Exercise 2.81 (2.3) 2.773 (2.5) 2.92 (2.2) t (174) = -.544, p >.05 
Blood glucose testing 4.98 (2.5) 5.20 (2.4) 4.67 (2.6) t (170) = 1.39, p >.05 
Foot care 4.20 (1.5) 4.22 (1.4) 4.17 (1.5) t (163) = .214, p >.05 
Psychological Variables     
Perceived Generalized Stress 29.23 (8.0) 29.67 (8.2) 28.63 (7.6) t (173) = .849, p >.05 
Positive Affect 27.06 (8.2) 27.02 (8.1) 27.11 (8.4) t (171) = -.072, p >.05 
Negative Affect 23.96 (8.1) 24.49 (8.6) 23.23 (7.4) t (175) = 1.01, p >.05 
Depression 9.75 (5.9) 10.27 (6.23) 9.01 (5.4) t (157) = 1.31, p >.05 
Anxiety 7.92 (5.2) 8.40 (5.3) 7.24 (5.1) t (159) = 1.39, p >.05 
Diabetes-Related Distress 46.86 (24.4) 48.0 (25.6) 45.3 (22.5) t (175) = .721, p >.05 
History of Psychotherapy 99 (55.9) 59 (57.3) 40 (54.1) X2 (1) = .182, p >.05 
Current Psychotropic Medication 60 (33.9) 37 (36.3) 23 (33.3) X2 (1) = .156, p >.05 
Stress Management in Past Week 4.13 (4.0) 4.24 (3.14) 3.97 (3.0) t (175) = .571, p >.05 
Note.  Values are M (SD) or n (%) as appropriate. 
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Table 3 
Baseline Characteristics of Participants Who Completed the Study in the Computerized Cognitive-Behavior for Stress Management 
(CCBT-SM) Group vs. the Waiting List Group 
  
Total 
Sample CCBT-SM 
Waiting 
List   
  (N = 108) (n = 49) (n = 59)   
Demographic Variables     
Age in years 55.05 (14.6) 57.22 (13.9) 53.24 (15.0) t (100) = 1.42, p > .05 
Women 80 (74.8) 36 (73.5) 44 (75.9) X2 (1) = .081, p > .05 
Caucasian 101 (93.5) 47 (95.9) 54 (91.5) X2 (1) = .852, p > .05 
Married 67 (62.0) 29 (59.2) 38 (64.4) X2 (1) = .310, p > .05 
College Graduate or Higher 65 (60.2) 28 (57.1) 37 (62.7) X2 (1) = .346, p > .05 
Diabetes-Related Variables     
Type 2 72 (66.7) 31 (63.3) 41 (69.5) X2 (1) = .467, p > .05 
Years Since Diagnosis 14.48 (11.0) 16.15 (12.6) 13.05 (9.4) t (100) = 1.420, p > .05 
Hemoglobin A1c 7.58 (1.4) 7.59 (1.2) 7.56 (1.6) t (62) = 0.09, p >.05 
Diabetes Symptoms (Total) 36.83 (26.5) 35.90 (23.6) 37.61 (28.9) t (106) = -0.33, p > .05 
       Sensory 0.78 (1.1) 0.91 (1.1) 0.68 (1.0) t (102) = 1.07, p >.05 
       Psychological Fatigue 2.15 (1.4) 2.11 (1.3) 2.19 (1.4) t (102) = -0.31, p >.05 
       Cognitive 1.60 (1.3) 1.48 (1.2) 1.69 (1.3) t (101) = -0.82, p >.05 
       Neurological Pain 0.54 (1.0) 0.44 (0.8) 0.63 (1.2) t (99) = -0.88, p >.05 
       Cardiac 0.65 (0.8) 0.59 (0.7) 0.70 (0.9) t (102) = -0.69, p >.05 
       Ophthalmologic 0.58 (1.0) 0.59 (0.9) 0.58 (1.1) t (104) = -0.04, p >.05 
       Hypoglycemic 1.61 (1.2) 1.49 (1.2) 1.71 (1.2) t (102) = -0.94, p >.05 
       Hyperglycemic 1.19 (1.1) 1.22 (1.1) 1.16 (1.2) t (101) = .25, p >.05 
Ability to Manage Diabetes     
       Horrible 4 (3.7) 2 (4.1) 3 (3.4) X2 (1) = .036, p > .05 
       Poor 10 (9.3) 4 (8.2) 6 (10.2)  X2 (1) = .128, p > .05 
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Total 
Sample CCBT-SM 
Waiting 
List   
  (N = 108) (n = 49) (n = 59)   
       Fair 40 (37.0) 21 (42.9) 19 (32.2) X2 (1) = 1.303, p > .05 
       Good 42 (38.9) 18 (36.7) 24 (40.7) X2 (1) = .175, p > .05 
       Excellent 9 (8.3) 4 (8.2) 5 (8.5) X2 (1) = .003, p > .05 
Oral Diabetes Medication 70 (64.8) 33 (67.3) 37 (62.7) X2 (1) = .252, p > .05 
Insulin 66 (61.1) 31 (63.3) 35 (59.3) X2 (1) = .175, p > .05 
Chronic Illnesses 3.76 (2.7) 4.10 (2.8) 3.47 (2.5) t (106) = 1.23, p >.05 
Adherence to Diabetes Regimen     
General diet 4.50 (1.8) 4.64 (1.9) 4.37 (1.6) t (105) = 0.77, p >.05 
Specific diet 3.85 (1.6) 3.90 (1.6) 3.80 (1.6) t (104) = 0.34, p >.05 
Exercise 2.93 (2.3) 2.93 (2.5) 2.93 (2.2) t (106) = -0.01, p >.05 
Blood Glucose Testing 5.04 (2.5) 5.61 (2.1) 4.59 (2.6) t (102) = 2.14, p =.04 
Foot care 4.11 (1.5) 4.08 (1.4) 4.13 (1.6) t (96) = -0.14, p >.05 
Psychological Variables     
Perceived Generalized Stress 28.37 (8.0) 28.52 (8.8) 28.25 (7.3) t (105) = 0.17, p >.05 
Positive Affect 27.92 (8.1) 28.27 (7.3) 27.62 (8.8) t (104) = 0.41, p >.05 
Negative Affect 22.83 (7.9) 22.84 (8.8) 22.83 (7.1) t (106) = 0.004, p >.05 
Depression 9.08 (5.6) 9.24 (5.8) 8.94 (5.4) t (96) = 0.27, p >.05 
Anxiety 7.16 (5.2) 7.36 (5.4) 7.00 (5.0) t (93) = 0.33, p >.05 
Diabetes-Related Distress 44.36 (24.2) 43.52 (26.8) 45.06 (22.0) t (106) = -0.33, p >.05 
History of Psychotherapy 57 (52.8) 21 (53.1) 31 (52.5) X2 (1) = .003, p > .05 
Current Psychotropic Medication 31 (29.5) 16 (32.7) 16 (26.8) X2 (1) = .432, p > .05 
Stress management in Past Week 4.33 (3.1) 4.63 (3.2) 4.08 (3.1) t (106) = 0.91, p >.05 
Note.  Values are M (SD) or n (%) as appropriate. 
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Table 4 
Baseline Characteristics of Participants who Completed the Study and Those who Did Not Complete the Study  
  Total Sample 
Non-
Completers Completers   
  (N = 177) (n = 69) (n = 108) 
Demographic Variables     
Age in years 5.13 (13.85) 55.25 (12.7) 55.05 (14.6) t (174) =0.10, p >.05 
Women 130 (73.4) 50  (72.5) 80 (74.8) X2 (1) = .0.12, p > .05 
Caucasian 161 (91.0) 60 (87.0) 101 (93.5) X2 (1) = 2.21, p > .05 
Married 106 (59.9) 39 (56.5) 67 (62.0) X2 (1) = 0.53, p > .05 
College Graduate or Higher 104 (58.7) 39 (56.5) 65 (60.2) X2 (1) = 0.23, p > .05 
Diabetes-Related Variables     
Type 2 117 (66.1) 45 (65.2) 72 (66.7) X2 (1) = 0.04, p > .05 
Years Since Diagnosis 15.41 (12.7) 16.89 (14.9) 14.48 (11.0) t (164) = 1.20, p > .05 
Hemoglobin A1c 7.60 (1.3) 7.74 (1.0) 7.56 (1.4) t (79) = 0.490, p > .05 
Diabetes Symptoms (Total) 39.25 (28.4) 43.03 (31.0) 36.83 (26.5) t (175) = 1.42, p > .05 
       Sensory 0.91 (1.13) 1.10 (1.2) 0.78 (1.1) t (169) = 1.81, p > .05 
       Psychological Fatigue 2.21 (1.36) 2.31 (1.4) 2.15 (1.4) t (169) = 0.72, p > .05 
       Cognitive 1.69 (1.36) 1.84 (1.3) 1.60 (1.3) t (168) = 1.20, p > .05 
       Neurological Pain 0.57 (1.0) 0.61 (1.0) 0.54 (1.0) t (165) = 0.43, p > .05 
       Cardiac 0.75 (0.9) 0.90 (1.1) 0.65 (0.8) t (171) = 1.70, p > .05 
       Ophthalmologic 0.62 (1.0) 0.67 (0.9) 0.58 (1.0) t (168) = 0.56, p > .05 
       Hypoglycemic 1.67 (1.2) 1.74 (1.3) 1.61 (1.2) t (171) = 0.69, p > .05 
       Hyperglycemic 1.29 (1.2) 1.46 (1.4) 1.19 (1.1) t (165) = 1.39, p > .05 
Ability to Manage Diabetes     
       Horrible 6 (3.4) 2 (2.9) 4 (3.7) X2 (1) = .0.08, p > .05 
       Poor 24 (13.6) 14 (20.3) 10 (9.3) X2 (1) = 4.37, p = .04 
       Fair 63 (35.6) 23 (33.3) 40 (37.0) X2 (1) = 0.25, p > .05 
       Good 66 (37.3) 24 (34.8) 42 (38.9) X2 (1) = 0.30, p > .05 
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  Total Sample 
Non-
Completers Completers   
  (N = 177) (n = 69) (n = 108) 
     
       Excellent 15 (8.5) 6 (8.7) 9 (8.3) X2 (1) = 0.01, p > .05 
Oral Diabetes Medication 108 (61.0) 38 (55.1) 70 (64.8) X2 (1) = 1.68, p > .05 
Insulin 106 (59.9) 40 (58.0) 66 (61.1) X2 (1) = 0.17, p > .05 
Chronic Illnesses 3.97 (2.9) 4.30 (3.2) 3.76 (2.6) t (175) =1.24, p > .05 
Adherence to Diabetes Regimen     
General diet 4.38 (1.8) 4.22 (1.8) 4.50 (1.8) t (173) = -0.98, p > .05 
Specific diet 3.84 (1.6) 3.82 (1.7) 3.85 (1.6) t (172) =-0.11, p > .05 
Exercise 2.81 (2.3) 2.63 (2.4) 2.93 (2.3) t (174) = -0.84, p > .05 
Blood Glucose Testing 4.98 (2.5) 4.88 (2.5) 5.04 (2.5) t (170) = -0.40, p > .05 
Foot care 4.20 (1.5) 4.33 (1.4) 4.11 (1.5) t (163) = 0.97, p > .05 
Psychological Variables     
Perceived Generalized Stress 29.23 (8.0) 30.59 (7.8) 28.37 (8.0) t (173) = 1.81, p > .05 
Positive Affect 27.06 (8.2) 25.70 (8.2) 27.92 (8.1) t (171) = -1.74, p > .05 
Negative Affect 23.96 (8.1) 25.72 (8.2) 22.83 (7.9) t (175) = 2.34, p = .02 
Depression 9.75 (5.9) 10.84 (6.4) 9.08 (5.6) t (157) = 1.83, p > .05 
Anxiety 7.92 (5.2) 9.02 (5.2) 7.16 (5.17) t (159) = 2.24, p = .03 
Diabetes-Related Distress 46.86 (24.4) 50.78 (24.3) 44.36 (24.2)  t (175) = 1.72, p > .05 
History of Psychotherapy 99 (55.9) 42 (60.9) 57 (52.8) X2 (1) = 1.12, p > .05 
Current Psychotropic Medication 60 (33.9) 29 (43.9) 31 (29.5) X2 (1) = 3.70, p > .05 
Stress management in Past Week 4.13 (4.0) 3.81 (3.05) 4.33 (3.12) t (175) = -1.09, p > .05 
Note.  Values are M (SD) or n (%) as appropriate. 
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Table 5 
 
Correlations of A1c with Outcome Variables at Baseline & Final Assessment 
Variable 
Baseline A1c & Q1 
Correlations 
(n = 64) 
Final A1c & Q3 
Correlations 
(n = 54) 
Perceived Generalized Stress -.01  .07 
Diabetes-Related Distress  .25*  .23 
Depression -.09  .14 
Anxiety -.03  .08 
Positive Affect  .20 -.08 
Negative Affect  .01  .16 
Diabetes Symptoms (Total)  .18  .11 
Fatigue Symptoms  .06 -.01 
Cognitive Symptoms  .11 -.04 
Neurological Pain Symptoms  .23  .23 
Sensory Symptoms  .03  .28* 
Cardiac Symptoms  .11  .15 
Opthomological Symptoms  .33**  .09 
Hypoglycemia Symptoms -.10 -.77 
Hyperglycemia Symptoms  .20  .11 
General Diet Recommendations -.39** -.01 
Specfic Diet Recommendatons -.23 -.01 
Exercise Recommendations  .03  .17 
Glucose Testing Recommendations -.02 -.01 
Foot Care Recommendation -.09 -.13 
*p < .05.  **p < .01. 
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Table 6 
 
Correlations of Psychological Outcomes with Diabetes Outcomes and Adherence at Baseline 
Variable Perceived Generalized Stress 
Diabetes-
Related Distress     Depression    Anxiety 
Positive  
Affect 
Negative 
Affect 
Diabetes Symptoms (Total)  .47**  .53**  .67**  .44** -.32**  .51** 
Fatigue   .44**  .45**  .63**  .40** -.34**  .43** 
Cognitive   .46**  .45**  .62**  .44** -.38**  .51** 
 Pain   .30**  .31**  .42**  .37* -.09  .24* 
Sensory   .26**  .31**  .42**  .23* -.18  .29** 
Cardiac   .33**  .30**  .45**  .21* -.21*  .35** 
Ophthalmologic  .20*  .22*  .27**  .22* -.07  .17 
Hypoglycemic  .54**  .49**  .56**  .54** -.35**  .56** 
Hyperglycemic  .21*  .48**  .42**  .28** -.11  .33** 
Adherence to Recommendations       
General diet -.29** -.21* -.18 -.03  .23* -.09 
Specific diet -.31** -.17 -.22* -.14  .26** -.21* 
Exercise -.35** -.07 -.24* -.08  .28** -.18 
Glucose testing -.05  .06 -.05  .09  .16  .03 
Foot care  .03 -.01  .03  .13 -.01  .11 
*p < .05.  **p < .01. 
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Table 7 
 
Correlations of Psychological Outcomes with Diabetes Outcomes and Adherence at Final Assessment   
Variable 
Perceived 
Generalized 
Stress 
Diabetes-Related 
Distress Depression Anxiety 
Positive  
Affect 
Negative 
Affect 
Diabetes Symptoms (Total)  .33**  .46**  .64**  .51** -.23* .50** 
Fatigue   .49**  .39**  .75**  .59** -.33** .53** 
Cognitive   .48**  .47**  .76**  .64** -.35** .58** 
 Pain   .26**  .34**  .39**  .39** -.22* .39** 
Sensory   .16  .38**  .40**  .33** -.18 .35* 
Cardiac   .28**  .39**  .53**  .41** -.17 .51** 
Ophthalmologic  .19  .32**  .38**  .39** -.12 .44** 
Hypoglycemic  .57**  .42**  .67**  .69** -.32** .71** 
Hyperglycemic  .23*  .42**  .58**  .46** -.07 .47** 
Adherence to Recommendations       
General diet -.23* -.16 -.13 -.07  .32** -.04 
Specific diet -.14 -.15 -.22* -.14  .32** -.09 
Exercise -.15 -.11 -.12   .00  .23* -.08 
Glucose testing -.13 -.13 -.15 -.12  .14 -.21* 
Foot care -.05 -.04 -.08 -.04  .11  .01 
*p < .05. **p < .01. 
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Table 8 
 
ANCOVAs Examining the Effect of CCBT-SM on Psychological Distress Variables 
 
  Baseline   Final                                   
 CCBT-SM  Waiting List  CCBT-SM  Waiting List  
  n M SD   n M SD   M SD   M SD F p Cohen's d ηp
2 
Perceived Stress 48 28.52 8.8  57 28.53 7.2  19.96 8.9  27.26 8.5 25.3 <.01 0.84 .199 
Diabetes-Related Distress 49 43.52 26.8  59 45.06 22.0  28.95 22.6  40.89 21.5 13.45 <.01 0.54 .114 
Depression 42 9.00 5.9  51 9.06 5.4  5.95 5.5  8.04 5.1 7.06 .01 0.40 .073 
Anxiety 41 7.39 5.5  51 7.18 5.0  4.44 4.7  6.57 5.5 6.78 .01 0.41 .071 
Positive Affect 47 28.09 7.2  58 27.62 8.8  29.3 9.1  27.26 8.8 1.64 .20 0.23 .016 
Negative Affect 49 22.84 8.8   57 23.09 7.1   17.16 7.3   21.6 8.5 13.02 <.01 0.56 .112 
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Table 9 
 
ANCOVAs Examining the Effect of CCBT-SM on Diabetes Symptoms and A1c 
  Baseline   Final         
 CCBT-SM 
 
Waiting List 
 
CCBT-SM  Waiting List    
 
  n M SD   n M SD   M SD   M SD F p Cohen's d ηp
2 
Total Diabetes Symptoms 49 35.90 23.6  59 37.61 28.9  32 23.7  39.17 29.7 2.54 .11 0.26 .024 
Fatigue 48 2.14 1.3  53 2.17 1.4  1.62 1.4  2.18 1.4 7.34 .01 0.4 .070 
Cognitive 41 1.44 1.2  57 1.67 1.4  1.13 1.1  1.71 1.3 6.4 .01 0.48 .063 
Neurological 45 0.45 0.8  51 0.64 1.2  0.24 0.5  0.39 0.9 0.26 .61 0.20 .003 
Sensory 46 0.92 1.2  54 0.62 1.0  0.7 1.0  0.54 0.9 0.03 .85 0.17 .000 
Cardiac 44 0.53 0.6  53 0.72 0.9  0.44 0.8  0.67 1.0 0.47 .50 0.25 .005 
Ophthalmologic 45 0.56 0.9  55 0.50 1.0  0.45 0.9  0.52 1.0 0.44 .51 0.07 .005 
Hyperglycemic 44 1.23 1.1  54 1.15 1.2  0.69 0.8  1.09 1.1 11.16 <.01 0.41 .105 
Hypoglycemic 45 1.48 1.2  56 1.73 1.2  0.78 0.9  1.32 1.1 6.16 .02 0.53 .059 
A1c 21 7.35 0.9   25 7.65 1.7   7.26 1.0   7.58 1.4 0.28 .60 0.26 .007 
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Table 10 
 
The Indirect Effect of CCBT-SM on Fatigue through Psychological Distress Measures 
Mediator a b c’ c ab [BCa 95% CI] abcs [BCa95% CI]   PM 
Perceived Generalized Stress   7.69** 0.07* 0.01 0.58* 0.57 [.31, .93] 0.20 [.11, .32] 0.99 
Diabetes-Related Distress 11.27* 0.02** 0.29 0.56* 0.26 [.07, .60] 0.09 [.02, .20] 0.48 
Depression 2.56* 0.19** 0.08 0.58* 0.50 [.02, .97] 0.17 [.01, .32] 0.86 
Anxiety 2.51* 0.16** 0.10 0.50  0.40 [.08, .73] 0.14 [.02, .25] 0.79 
Negative Affect   4.22** 0.09** 0.23 0.61* 0.38 [.12, .73] 0.13 [.04, .25] 0.62 
Note.  See Figure 6 for diagram of relationship between variables.  a = the slope of the mediator regressed on the intervention, b = the 
slope of psychological fatigue regressed on the mediator controlling for the intervention, c’ = the slope of the direct effect of the 
intervention on psychological fatigue, c = the slope of the indirect effect of the intervention on psychological fatigue through the 
mediator, ab = the indirect effect of the intervention on psychological fatigue through the mediator, abcs = completely standardized 
indirect effect, PM = the ratio of the indirect effect to the total effect. 
* p < .05, ** p < .01  
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Table 11 
The Indirect Effect of CCBT-SM on Cognitive Symptoms through Psychological Distress Measures 
Mediator a b c’ c ab [BCa 95% CI] abcs [BCa 95% CI]   PM 
Perceived Generalized Stress  7.66** 0.06** 0.17 0.61* 0.44 [.22, .76] 0.18 [.09, .31] 0.72 
Diabetes-Related Distress  13.45** 0.02** 0.29 0.61* 0.31 [.11, .66] 0.13 [.05, .26] 0.51 
Depression   2.91** 0.17** 0.12 0.60* 0.48 [.17, .85] 0.20 [.07, .34]  0.80 
Anxiety   2.89** 0.15** 0.18 0.61* 0.43 [.20, .71] 0.17 [.08, .28]  0.70 
Negative Affect  5.05** 0.08** 0.26  0.67** 0.41 [.19, .72] 0.17 [.08, .29] 0.61 
Note.  See Figure 6 for diagram of relationship between variables.  a = the slope of the mediator regressed on the intervention, b = 
the slope of cognitive symptoms regressed on the mediator controlling for the intervention, c’ = the slope of the direct effect of the 
intervention on cognitive symptoms, c = the slope of the indirect effect of the intervention on cognitive symptoms through the 
mediator, ab = the indirect effect of the intervention on cognitive symptoms through the mediator, abcs = completely standardized 
indirect effect, PM = the ratio of the indirect effect to the total effect. 
* p < .05. ** p < .01.  
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Table 12 
 
The Indirect Effect of CCBT-SM on Hyperglycemic Symptoms through Psychological Distress Measures 
Mediator a b c’ c ab [BCa 95% CI] abcs [BCa 95% CI]   PM 
Perceived Generalized Stress  7.66**   0.02 0.18 0.34 0.16 [.002, .39] 0.08 [.00, .19] 0.46 
Diabetes-Related Distress   12.71**   0.02** 0.13 0.36 0.23 [.06, .50] 0.11 [.03, .22] 0.63 
Depression   2.33*  0.11** 0.12 0.37 0.25 [.03, .57] 0.12 [.02, .27] 0.68 
Anxiety   2.44*  0.08** 0.21   0.41* 0.20 [.05, .43] 0.10 [.02, .21] 0.49 
Negative Affect   4.53**  0.05** 0.14 0.39 0.25 [.07, .52] 0.12 [.04, .25] 0.64 
Note.  See Figure 6 for diagram of relationship between variables.  a = the slope of the mediator regressed on the intervention, b = the 
slope of hyperglycemic symptoms regressed on the mediator controlling for the intervention, c’ = the slope of the direct effect of the 
intervention on hyperglycemic symptoms, c = the slope of the indirect effect of the intervention on hyperglycemic symptoms through 
the mediator, ab = the indirect effect of the intervention on hyperglycemic symptoms through the mediator, abcs = completely 
standardized indirect effect, PM = the ratio of the indirect effect to the total effect. 
* p < .05. ** p < .01.  
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Table 13 
 
The Indirect Effect of CCBT-SM on Hypoglycemic Symptoms through Psychological Distress Measures 
Mediator a b c’ c ab [BCa 95% CI] abcs [BCa 95% CI]   PM 
Perceived Generalized Stress  8.41** 0.06** 0.11  0.63** 0.51 [.30, .82] 0.24 [.15, .38] 0.82 
Diabetes-Related Distress  12.70** 0.02** 0.36  0.58** 0.22 [.06, .48] 0.10 [.03, .22] 0.38 
Depression   2.89** 0.13** 0.19 0.55* 0.36 [.12, .67] 0.17 [.05, .30] 0.66 
Anxiety   2.69** 0.13** 0.22  0.58** 0.36 [.10, .65] 0.17 [.05, .29] 0.63 
Negative Affect  4.93** 0.09** 0.16  0.60** 0.44 [.20, .74] 0.21 [.10, .34] 0.74 
Note.  See Figure 6 for diagram of relationship between variables.  a = the slope of the mediator regressed on the intervention, b = the 
slope of hypoglycemic symptoms regressed on the mediator controlling for the intervention, c’ = the slope of the direct effect of the 
intervention on hypoglycemic symptoms, c = the slope of the indirect effect of the intervention on hypoglycemic symptoms through 
the mediator, ab = the indirect effect of the intervention on hypoglycemic symptoms through the mediator, abcs = completely 
standardized indirect effect, PM = the ratio of the indirect effect to the total effect. 
p < .05. ** p < .01  
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Table 14 
 
The Indirect Effect of CCBT-SM on Psychological Distress through Fatigue. 
Dependent Variable a b c’ c ab [BCa 95% CI] abcs [BCa 95% CI]    PM 
Perceived Generalized Stress 0.58* 2.85**  6.03**  7.69** 1.65 [0.14, 3.56] 0.09 [.01, .18] 0.22 
Diabetes-Related Distress 0.56* 5.67**  8.12 11.27* 3.15 [0.42, 7.41] 0.07 [.01, .16] 0.28 
Depression 0.58* 2.81**  0.92  2.56* 1.64 [-0.04, 3.45]  0.15 [-.01, .29] 0.64 
Anxiety   0.50 2.05**  1.49  2.51* 1.02 [0.01, 2.31]  0.10 [-.01, .21] 0.41 
Negative Affect 0.61* 2.89**  2.47  4.22** 1.75 [0.32, 3.52]     0.11 [.02, .20] 0.42 
Note.  See Figure 7 for diagram of relationship between variables.  a = the slope of the fatigue regressed on CCBT-SM, b = the slope 
of psychological distress regressed on fatigue controlling for CCBT-SM, c’ = the slope of the direct effect of  CCBT-SM on 
psychological distress, c = the slope of the indirect effect of CCBT-SM on psychological distress through fatigue, ab = the indirect 
effect of CCBT-SM on psychological distress through fatigue, abcs = completely standardized indirect effect, PM = the ratio of the 
indirect effect to the total effect. 
p < .05. ** p < .01.  
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Table 15 
The Indirect Effect of CCBT on Psychological Distress through Cognitive Symptoms. 
Dependent Variable a b c’ c ab [BCa 95% CI] abcs [BCa95% CI]  PM 
Perceived Generalized Stress  0.61* 3.26**  5.69** 7.66** 1.97 [0.67, 4.02] 0.10 [.04, .20]  0.26 
Diabetes-Related Distress  0.61* 7.73** 8.76* 13.45** 4.69 [1.32, 9.32] 0.10 [.03, .20]  0.35 
Depression   0.60* 3.30**   0.93 2.91** 1.98 [0.41, 3.37] 0.18 [.03, .30]  0.68 
Anxiety   0.61* 2.53**   1.35 2.89** 1.54 [0.41, 2.82] 0.15 [.04, .26]  0.53 
Negative Affect    0.67** 3.55**   2.67 5.05** 2.37 [0.94, 4.29] 0.15 [.06, .26]  0.47 
Note.  See Figure 7 for diagram of relationship between variables.  a = the slope of cognitive symptoms regressed on CCBT-SM, b = 
the slope of psychological distress regressed on cognitive symptoms controlling for CCBT-SM, c’ = the slope of the direct effect of  
CCBT-SM on psychological distress, c = the slope of the indirect effect of CCBT-SM on psychological distress through cognitive 
symptoms, ab = the indirect effect of CCBT-SM on psychological distress through cognitive symptoms, abcs = completely 
standardized indirect effect, PM = the ratio of the indirect effect to the total effect. 
p < .05. ** p < .01.  
 70 
Table 16 
 
The Indirect Effect of CCBT-SM on Psychological Distress through Hyperglycemic Symptoms 
Dependent Variable a     b c’ c ab [BCa 95% CI] abcs [BCa 95% CI]    PM 
Perceived Generalized Stress  0.34  1.57  7.13**   7.66** 0.53 [-0.02, 1.92]     . 03 [.00, .10] 0.07 
Diabetes-Related Distress  0.36 8.49**  9.64* 12.71** 3.06 [-0.00, 7.26] .07 [.00, .16] 0.24 
Depression   0.37 2.93**  1.26   2.33* 1.08 [0.13, 2.43] .10 [.01, .22] 0.46 
Anxiety     0.41* 2.21**  1.54 2.44* 0.90 [0.15, 2.12] .09 [.01, .20] 0.37 
Negative Affect    0.39 3.53**  3.16*   4.52** 1.37 [0.26, 3.28] .08 [.02, .18] 0.30 
Note.  See Figure 7 for diagram of relationship between variables.  a = the slope of hyperglycemic symptoms regressed on CCBT-
SM, b = the slope of psychological distress regressed on hyperglycemic symptoms controlling for CCBT-SM, c’ = the slope of the 
direct effect of  CCBT-SM on psychological distress, c = the slope of the indirect effect of CCBT-SM on psychological distress 
through hyperglycemic symptoms, ab = the indirect effect of CCBT-SM on psychological distress through hyperglycemic symptoms, 
abcs = completely standardized indirect effect,  PM = the ratio of the indirect effect to the total effect. 
p < .05. ** p < .01. 
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Table 17 
The Indirect Effect of CCBT-SM on Psychological Distress through Hypoglycemic Symptoms. 
Dependent Variable a   c’ c ab [BCa 95% CI] abcs [BCa 95% CI]   PM 
Perceived Generalized Stress  0.63** 4.27** 5.74** 8.41** 2.67 [1.09, 4.67] .14 [.06, .23] 0.32 
Diabetes-Related Distress  0.58** 8.00**  8.08 12.70** 4.62 [1.62, 9.30] .10 [.04, .19] 0.36 
Depression    0.55* 3.31**  1.07 2.89** 1.83 [0.67, 3.33] .17 [.06, .29] 0.63 
Anxiety    0.58** 3.30**  0.77 2.69** 1.91 [0.66, 3.53] .18 [.06, .33] 0.71 
Negative Affect   0.50** 5.25**  1.80 4.93** 3.13 [1.26, 5.47] .19 [.07, .31] 0.63 
Note.  See Figure 7 for diagram of relationship between variables.  a = the slope of hypoglycemic symptoms regressed on CCBT-SM, 
b = the slope of psychological distress regressed on hypoglycemic symptoms controlling for CCBT-SM, c’ = the slope of the direct 
effect of  CCBT-SM on psychological distress, c = the slope of the indirect effect of CCBT-SM on psychological distress through 
hypoglycemic symptoms, ab = the indirect effect of CCBT-SM on psychological distress through hypoglycemic symptoms, abcs = 
completely standardized indirect effect, PM = the ratio of the indirect effect to the total effect. 
p < .05. ** p < .01. 
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Table 18 
ANCOVAs Examining the Effect of CCBT-SM on Adherence to Diabetes Regimen 
  Baseline   Final         
 CCBT-SM  
Waiting List 
 
CCBT-SM  Waiting List     
  n M SD 
  
n M SD   M SD   M SD F p Cohen's d ηp
2 
General Diet  48 4.64 1.9 
 
58 4.37 1.7  4.76 1.9  4.5 1.8 0.08 .78 0.14 .001 
Specific Diet 48 3.90 1.6 
 
57 3.84 1.5  4.15 1.5  4.18 1.4 0.14 .71 0.02 .001 
Exercise 48 2.96 2.5 
 
59 2.93 2.2  3.04 2.2  2.58 2.1 2.26 .14 0.21 .021 
Blood Glucose Testing 46 5.61 2.1 
 
58 4.59 2.6  5.86 2.0  4.96 2.5 0.17 .69 0.39 .002 
Foot Care 42 4.06 1.4   53 4.13 1.6   4.4 1.5   4.4 1.7 0.11 .75 0.00 .106 
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  Excluded  (n= 347) 
♦ Not meeting inclusion criteria (n=142) 
♦ Declined to participate (n= 70) 
Completed study (Q3) in Intervention 
group  (n = 49) 
 
Lost to follow-up (n=21) 
(12 withdrew without specifying a reason, 2 stated 
that the study was too stressful, 2 stated that the 
program was “not for [them],” 3 experienced 
paperwork or technical issues, 2 stated that they 
didn’t have enough time)  
Allocated to intervention (n= 103) 
♦ Received allocated intervention (n= 75) 
♦ Did not receive allocated intervention 
(participants did not complete any self-checks 
or log onto website; n= 28) 
Lost to follow-up  (n=12) 
(8 withdrew without specifying a reason, 1 
stated that the program was too stressful, 1 
stated that the program was “not for [them],” 1 
stated that they didn’t have enough time, 1 
stated that she was no longer had a diabetes 
diagnosis)  
Allocated to control (n= 74) 
 
 
Completed study (Q3) in control 
group (n = 59) 
 
Allocation 
Analysis 
Follow-Up 
Randomized (n= 177) 
Enrollment 
 Completed Q1 (n= 182) 
Excluded  (n= 5) 
Figure 3. CONSORT diagram of participant flow 
Did not complete Q1 (n= 35) 
Consented (n= 217) 
Assessed for eligibility (n= 529) 
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Figure 4. The interaction between baseline negative affect scores and group. 
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Figure 5.  The interaction between baseline hyperglycemic symptoms and group. 
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Figure 6.  Conceptual Mediation Diagram.  a = the slope of the mediator regressed on the 
intervention, b = the slope of diabetes symptoms regressed on the mediator controlling for the 
intervention, c’ = the slope of the direct effect of the intervention on diabetes symptoms, c = the 
slope of the indirect effect of the intervention on diabetes symptoms through the mediator 
(Preacher & Kelly, 2001). 
 
 
Psychological	  Distress	  
(Mediator)	  
Diabetes	  Symptoms	  CCBT-­‐SM	  
a	  
	  c’	  
c	  
b	  
  77 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.  Mediation diagram displaying an alternative explanation of the relationships between 
group placement, diabetes symptoms, and psychological distress.   a = the slope of the mediator 
regressed on group assignment, b = the slope of psychological distress regressed on the mediator 
controlling for group assignment, c’ = the slope of the direct effect of group assignment on 
psychological distress, c = the slope of the indirect effect of group assignment on psychological 
distress through the mediator (Preacher & Kelly, 2001)  
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Chapter Four 
Discussion 
 The current study found that an online stress and mood management intervention reduced 
psychological distress and several types of diabetes symptoms in adults with type 1 and type 2 
diabetes. The nine-week program provided participants in the intervention group Internet-based 
education about managing stress, preventing mood problems, and identifying and seeking 
treatment for anxiety and depression.  Participation in the program led to decreased perceived 
generalized stress, decreased diabetes-related distress, decreased symptoms of depression and 
anxiety, and decreased negative affect compared to those who were placed on a waiting list.  The 
intervention also reduced several clusters of diabetes symptoms, including fatigue, cognitive 
symptoms, hypoglycemic symptoms, and hyperglycemic symptoms. Further, it demonstrated an 
indirect effect of the intervention on improved diabetes symptoms through psychological 
distress.  However, the program did not have an effect on A1c or adherence to diabetes 
management recommendations. 
Efficacy of CCBT-SM on Psychological Distress 
The CCBT-SM intervention employed in the current study led to a reduction across 
multiple types of psychological distress, i.e., perceived generalized stress, diabetes-related 
distress, depression, anxiety, and negative affect.  These results contribute to a large body of 
literature that has shown the efficacy of CBT for alleviating symptoms of depression, anxiety, 
and stress in the general population (Hofmann, Asnaani, Vonk, Sawyer, & Fang, 2012).  It also 
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adds to a smaller, but growing, body of research on the use of CBT in people with diabetes 
showing improvements in depression (Henry et al., 1997; Lustman et al., 1998; Welschen et al., 
2013), diabetes-related stress (Karlsen et al., 2004), stress, and anxiety (Henry et al., 1997). 
The use of CCBT is in this study provides an innovative way to utilize CBT.  The 
Internet-based nature of CCBT-SM provided an alternative to face-to-face therapy that included 
the primary components of CBT while overcoming barriers to traditional psychotherapy, such as 
stigma, distrust of therapists, discomfort discussing personal problems, logistical issues, physical 
limitations, and financial constraints (Cartreine et al., 2010; Cuijpers et al., 2008).  The current 
results are consistent with previous research that has demonstrated the efficacy of Internet or 
computer-based psychological treatments for the treatment of anxiety, depression, and general 
distress (Andersson & Cuijpers, 2009; Reger & Gahm, 2009; Spek et al., 2007) and for 
improvements in stress (Billings et al., 2008; Zetterqvist et al., 2003) in nonmedical populations. 
The current study produced effect sizes that were consistent with those seen in meta-
analyses of RCTs examining the efficacy of CCBT for depression and anxiety (Andersson & 
Cuijpers, 2009; Spek et al., 2007).  While other studies have noted greater effect sizes of CCBT 
for anxiety compared to depression (Spek et al, 2007), those seen in the current study were 
almost identical.  Interestingly, Spek et al. (2007) also reported that studies with minimal 
therapist interaction had an effect size that was smaller than the effect sizes seen in the current 
study, which also had minimal therapist contact.   
This study adds significantly to the scarce literature regarding the use of CCBT in people 
with diabetes.  Few researchers have conducted such studies and the two studies available are 
very different.  In one study, CCBT was employed in a six month RCT of a web-based well-
being intervention for adults over the age of 60 diagnosed with type 1 or type 2 diabetes that 
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targeted both diabetes self-management and psychosocial well-being (Bond et al., 2007). In the 
second study, CCBT was part of an eight-week web-based course that addressed psychological 
reactions to diabetes-specific topics in type1 and type 2 diabetics with elevated depression 
symptoms (van Bastelaar et al., 2011).  The results of the current study are consistent with these 
studies, which reported decreases in depression (Bond et al., 2007; van Bastelaar et al., 2011) 
and less diabetes-related distress (van Bastelaar et al., 2011).   The current study adds additional 
support for the use of CCBT in people with type 1 and type 2 diabetes.  It also suggests that these 
programs can be effective at reducing distress in this population without addressing diabetes 
management or diabetes-specific concerns and that this type of intervention is effective for a 
general adult diabetic population that does not report high baseline levels of depression 
symptoms. 
The current study differs from previous research in several ways.  The CCBT-SM 
intervention used in this study did not include many of the components that have been employed 
in other studies of CCBT in people with diabetes.  There was no contact with a coach or 
therapist, other than to remind them to log on to the program and complete their self-checks.   
This was a purely self-guided program and there was no way for participants to contact other 
participants.  In addition, the program focused solely on psychological distress.  It did not 
include any instruction on diabetes management nor did it address diabetes-specific distress.  It 
was up to the patient to apply the lessons to their experience of diabetes. 
Effect of CCBT-SM on Diabetes Outcomes 
The current study did not find an effect of the intervention on the primary indicator of 
diabetes control, A1c.  This is in contrast to other studies of face-to-face CBT interventions that 
have seen effects on A1c (Henry et al., 1997; Ismail et al., 2008; Karlsen et al., 2004; Lustman et 
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al., 1998) but consistent with a CCBT study that also did not find an effect of the intervention on 
A1c (vanBastelaar et al, 2011). 
One explanation for the lack of relationship is that the analyses in the current study were 
underpowered.  A recent meta-analysis of 30 studies concluded that stress management 
interventions have a medium effect on A1c  (Bykowski, Sacco, & Mayhew, 2011).  Thus, the 
study was originally powered for a regression analysis expecting a medium effect size, requiring 
107 participants.  It was later decided that an ANCOVA would be a more appropriate analysis 
and that would require 128 participants.  Unfortunately the acquisition of A1c lab test results 
from participants was a major barrier to the completion of the project and was eliminated as a 
requirement for participation.  While the researcher strived to collect valid A1c results from all 
participants, many participants did not have values that were measured at the correct relationship 
to the study questionnaires.  There were several participants who did not have their A1c 
measured often enough to be included in the study or did not provide the necessary authorization 
to obtain the A1c from their physicians.  As a result, the final sample had only 46 participants 
with both pre and post-study A1c.  Thus, at least three times the current sample size would have 
been necessary to see the expected effect.   
There were also surprisingly few significant correlations between A1c and other outcome 
variables.  Despite the very strong and well-established relationship between A1c and diabetes 
complications (Krishnamurti & Steffes, 2001), the only significant relationship in the current 
sample was between A1c and ophthalmologic symptoms at baseline and sensory symptoms at 
the final assessment.  In general, the correlations were in the expected direction, suggesting that 
the lack of significant relationships were likely due to the small sample size and, consequently, a 
lack of power in the analyses.  
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There were several significant correlations between the psychological variables and the 
symptom clusters at baseline and final assessment, suggesting that there is a relationship between 
psychological distress and diabetes symptoms.  However, there was no effect of the intervention 
on total diabetes symptoms. The lack of an effect of the intervention on diabetes symptoms may 
be due to a floor effect in the more severe symptom clusters.  At baseline, the sample reported 
few sensory, pain, cardiac, and ophthalmologic symptoms.  Indeed, the distributions of these 
symptom clusters were so skewed that applying transformations to the data did not result in a 
normal distribution. In addition, these symptoms represent more advanced diabetes 
complications that can take years to reverse (Krishanmurti & Steffes, 2001). It is likely that a 
nine-week period was not enough time to see a noticeable change in these more stable and severe 
symptoms.   
 In contrast, participants reported higher rates of psychological fatigue, cognitive 
symptoms, hypoglycemic symptoms, and hyperglycemic symptoms at baseline, giving these 
symptoms room to decrease.  These clusters are also comprised of more transient symptoms that 
are more likely to fluctuate over short periods of time (i.e., lack of energy, an overall sense of 
fatigue, sleepiness/drowsiness, difficulty concentrating, lack of energy, becoming easily irritated 
or annoyed, thirst, dry mouth).  Consistent with these features, these are the areas where the 
intervention had a significant effect.   These symptom clusters are also considered more 
psychological in nature (Arbuckle et al., 2009) and overlap with symptoms of stress, depression, 
and anxiety.  Thus, while considered to be proximal indicators of diabetes outcomes, they may 
have been directly targeted by the intervention. It should be noted that no previous studies of 
CCBT or CBT have examined the effect of the intervention on diabetes symptoms.   
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Psychological Distress as Mediator 
The results indicated indirect effects of the intervention on diabetes symptoms through 
psychological distress.  This supports the antecedent model, which suggests that psychological 
distress contributes to poor diabetes outcomes (Lustman et al., 2005; Musselman et al., 2003; 
Surwit & Schneider, 1993; Van Tilburg et al., 2001).  Taking this a step further, the antecedent 
model suggests that reducing psychological distress should improve diabetes outcomes, as this 
study has demonstrated.  
Previous research has shown that interventions which induce reductions in psychological 
distress also result in reductions in A1c (Gregg et al., 2007;   Kendardy et al., 2002; Lustman et 
al, 1997; Lustman et al., 1998).   However, previous CCBT interventions for people with 
diabetes (Bond et al, 2007; van Bastelaar et al., 2011) did not report on mediators or proposed 
mechanisms.  Thus this study provides the first evidence of the antecedent model as it relates to 
CCBT interventions.   
It was acknowledged that the cross-sectional nature of the mediation analyses also allows 
for the possibility of a consequence model, which posits that the experience of having diabetes 
(e.g., coping with adherence to medical recommendations or diabetes related medical symptoms) 
may create psychological distress (Kovacs et al., 1997; Palinkas et al., 1991; Sacco & Bykowski, 
2010).  To address this alternative explanation of the data, a second set of mediation analyses 
examined the indirect effect of the intervention on psychological distress through diabetes 
symptoms.  In most cases the indirect effects observed in these consequence model analyses 
were smaller than those seen in the antecedent model analyses.  In some cases the consequence 
mediation models were not significant, whereas all antecedent mediation models were 
significant.  This pattern suggests that the antecedent model better explains this data and 
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relationship between the variables.  However, it must also be noted that many of the differences 
between the consequence and antecedent models were small and many of the indirect effects in 
the consequence models were significant.  This was especially true for the models that included 
hypoglycemic symptoms.  Thus, more research into these models must be conducted.  It may 
also be possible that these models do not compete with each other, but actually complement each 
other in a bidirectional explanation of the relationship.   
Role of Adherence 
One proposed mechanism for the relationship between psychological distress and 
diabetes outcomes is through a behavioral pathway.  The behavioral pathway emphasizes the 
importance of adherence to a rigorous diabetes treatment regimen.  It has been suggested that 
those who experience distress may feel that self-care behaviors important to diabetes 
management are too difficult or they may not be motivated to perform the necessary tasks 
(Lloyd, Smith, & Weinger, 2005).    Not adhering to the treatment recommendations, in turn, 
leads to poorer diabetes outcomes (Centers for Disease Control and Prevention, 2014). The 
baseline data supported a relationship of adherence to general diet, specific diet, and exercise 
recommendations with perceived generalized stress as well as adherence to specific diet and 
exercise recommendations with depression.  This pattern is consistent with the results of other 
researchers who have noted that diabetes patients with high levels of depression or stress tend to 
have poorer diet and participate in less physical activity (Albright et al., 2001; Lin et al., 2004).  
However, the current study did not support the effect of CCBT-SM on adherence. The lack of 
effect of the intervention on adherence to diabetes recommendations is consistent with other 
RCTs of CBT in diabetics (Ismail et al., 2008; Lustman et al., 1998; van der Ven et. al., 2005).  
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However, one study did note an indirect effect of acceptance and commitment therapy on A1c 
through adherence (Gregg et al., 2007).  
The hypothesis that adherence would mediate the relationship between CCBT-SM and 
diabetes outcomes was not tested in the current study.  The lack of relationship between CCBT-
SM and adherence suggests that this relationship could not explain the relationship between 
CCBT-SM and diabetes outcomes.  Thus it was determined that the mediation analyses would be 
uninformative in this situation.  
Limitations 
 There are several limitations of this study that must be considered.   Foremost were the 
problems with recruitment and attrition that did not allow for the study to be conducted as 
originally proposed.  The original inclusion criteria, which required a minimum A1c of 6.5, 
eliminated a large number of interested individuals.  A concern regarding eliminating this 
criterion is that it could have resulted in floor effect for A1c.  That is, if baseline A1c was low, it 
might not have had room to decrease.   However, the majority (>80%) of the baseline A1c data 
obtained were still above 6.5%.  A larger concern was that, after eliminating the requirement of 
A1c prior to the start of participation, many participants did not provide A1c at all or within the 
specified time frame.  This significantly reduced the power in the analyses involving A1c, 
limiting the ability to draw valid conclusions from the data.  It is unclear whether the 
intervention would have had an effect on A1c if the analyses had been appropriately powered. 
A1c is the primary measure of glycemic control in people with diabetes and the lack of A1c data 
limits how the intervention relates to diabetes management.  Future research should continue to 
explore the ability of psychosocial interventions to influence A1c using methodology that is 
better able to answer this question.   
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A second limitation of the study was the high attrition rate.  Less than half of those 
assigned to the CCBT-SM group completed the study.  Others have noted that CCBT is 
associated with poor compliance and increased attrition (Ritterband et al., 2003) and have 
suggested that it may be easier for a client to disengage from a web-based therapy program than 
to cancel an appointment with a “real person” (Spek et al., 2007; Tate & Zabinski, 2004).  Those 
that did complete Q3 logged in to the program more times than expected, spent more time on the 
program than anticipated, and completed most of the weekly self-checks.  This pattern among 
those who completed Q3 is better engagement than was reported by Billings et al. (2008) in an 
RCT that used a very similar CCBT-SM program.  Thus, it appears that the additional structure 
of weekly emails, the division of the program into modules, self-checks, homework, and 
reminders increased adherence to the program.  Future research should determine ways to engage 
and retain participants. 
A third limitation is that the results of this study speak only to the ability of the 
intervention to affect psychological distress and diabetes outcomes over the nine-week course of 
the study.  There were no follow-up assessments; therefore, it cannot be determined whether 
CCBT-SM had a lasting effect.  Future research would benefit by including follow-up 
assessments that address this issue. Additional follow-ups may also allow for better explanation 
of the mechanisms.  The mediation analyses were conducted using cross-sectional data.  Using 
data from multiple time points may allow for better information regarding the direction of the 
effects and causality. 
A fourth limitation is that this study included both type 1 and type 2 diabetics.  While the 
symptoms and presentation of the conditions are very similar, their onsets, etiologies, and often 
their treatment regimens are different.  It is not clear whether this type of intervention would 
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have a greater impact on those with one type of diabetes compared to the other.  This issue was 
not examined in the current study due to insufficient power to compare the two groups.  Future 
research should look at whether CCBT-SM is more beneficial to one subset of diabetics. 
A fifth limitation of this study was that overall acceptability of the program was not 
assessed.  Critics of CCBT have suggested that it may seem impersonal or dehumanizing (Spek 
et al., 2007; Wright & Wright, 1997).  It is also possible that fully automated programs do not 
address all concerns that are important to clients (Cuijpers et al., 2008; Tate & Zabinski, 2004) 
and cannot detect subtle, nonverbal cues that indicate that the client is misunderstanding a 
concept (Cuijpers et al., 2008). The occurrence of these feelings in the participants was not 
assessed.  It is also assumed that this program was successful at overcoming the barriers to 
psychotherapy.  However, the patient’s perceptions of the ability of the program to overcome the 
issues related to stigma, concerns regarding psychotherapy, and logistical issues were not 
assessed.  Future research would benefit from additional surveys to create a program that is 
client-friendly and acceptable as well as effective to determine the extent to which patients 
would choose CCBT over face-to-face therapy. 
Clinical Implications 
Diabetes mellitus affects over 9% of the population of the United States and is the 
country’s seventh leading cause of death (Centers for Disease Control and Prevention, 2014).  In 
addition to the medical complications of uncontrolled diabetes that affect vision, kidney function, 
and the neurological and cardiovascular systems (Goldstein et al., 2004; Landell-Graham et al., 
2003), it also affects psychological health (Anderson et al., 2001; Eaton, 2002; Fenton & Stover, 
2006; Lustman et al., 1986; Scott et al., 2007).  One study noted that as many as 71% of diabetics 
experience psychological distress (Lustman et al., 1986) and it has been shown that people with 
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diabetes are twice as likely to experience depression (Anderson et al., 2001) compared to the 
general population.  Further, those with psychological distress and diabetes report poor overall 
physical functioning, (Ciechanowski et al., 2003), more symptoms of diabetes (Ciechanowski et 
al., 2003; Lustman et al., 1986) and more distress related to diabetes symptoms (Lustman et al., 
1986).  Diabetics who report symptoms of depression also experience higher rates of retinopathy, 
nephropathy, neuropathy, macrovascular complications and sexual dysfunction (de Groot et al., 
2001) and have more risk factors for cardiovascular disease (Katon et al., 2004).  Psychological 
distress has also been associated with worse adherence and glycemic control, more medical 
complications, higher hospitalization rates, and death at an earlier age (Anderson et al., 2001; 
Ciechanowski et al., 2000; de Groot et al., 2001; de Groot et al., 1999; Egede, 2006; Gilmer et 
al., 2005; Grandinetti et al., 2000; Lustman & Clouse, 2005; Lustman et al., 1986; Niemcryk et 
al., 1990; Wrigley & Mayou, 1991).  It is clear that this population is not only more at risk for 
experiencing distress, but also that the distress is related to negative health outcomes.  This study 
suggests that CCBT-SM offers a way to improve the mental health of diabetics as well as 
diabetes symptoms.   
Given the toll of psychological distress on the health of those with diabetes, the American 
Diabetes Association has dedicated a section of their Standards of Care stressing the importance 
of the detection and treatment of distress in routine diabetes care (American Diabetes 
Association, 2014).  However, only about one-third of diabetic patients who experience mental 
health concerns receive treatment  (Ducat, Philipson, & Anderson, 2014).  Physicians report 
several difficulties addressing the social and emotional concerns of their diabetic patients, 
including lack of expertise for treating these issues, few treatment options, difficulty identifying 
clinicians for referrals, and many patients who are not open to receiving mental health referrals 
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(Beverly, Hultgren, Brooks, Ritholz, Abrahmson, & Weinger, 2011). An online intervention can 
provide a useful tool to physicians and patients who otherwise would not feel comfortable 
addressing psychological concerns.  Thus, the CCBT-SM program used in this study provides a 
means for more clinics to meet the American Diabetes Association’s Standards of Care.  This 
may provide psychological and physical health benefits to a population at greater risk for the 
development of psychological distress compared to the general population. 
Future Directions 
The results of this study suggest that CCBT-SM may be a useful component of diabetes 
care.  However, this remains a relatively new form of treatment that opens the door to several 
lines of future research.  As with all new interventions, the study must be replicated to ensure 
that similar results are consistently achieved.  Future research would benefit from studying a 
larger, more diverse sample to ensure adequate power across all analyses.  As mentioned above, 
greater attention should be paid to A1c, which is a primary indicator of diabetes management.  
However, other diabetes outcomes and physical health outcomes, such as cardiovascular risk 
factors (i.e., cholesterol, blood pressure, body mass index), markers of inflammation (i.e., CRP), 
and lifestyle factors (i.e., smoking status) should also be examined. Working with physicians to 
collect these data in a more systematic way would also provide more reliable information than 
obtaining the information from medical records as was done in this study. 
Future research on a larger, more diverse sample would also allow for the examination of 
possible moderators of intervention efficacy.  Determining whether the intervention is more 
efficacious for individuals with certain characteristics would be helpful in understanding how the 
intervention works as well as who would benefit most.  For example, the ANCOVA analyses 
indicated that the intervention reduced negative affect more for those who started with higher 
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baseline negative affect and the intervention was more effective as lowering hyperglycemia for 
those with higher baseline hyperglycemia.  It is possible that the intervention would have a 
differential effect on those who started with more or less psychological distress or with better or 
worse diabetes control.  The technology component of CCBT-SM may also make the 
intervention more effective for those who are more comfortable with technology compared to 
those who are not as comfortable with it.   
Additional research on mechanisms is also necessary.  This study examined the 
behavioral pathway as the possible link between diabetes distress and diabetes outcomes.  
Unfortunately this pathway was not supported.  A physiological pathway, which implicates the 
HPA axis, has also been suggested as the mechanism driving the relationship between 
psychological distress and diabetes outcomes (Black, 2006; Rosmond, 2005).  Future research 
would benefit from measuring HPA axis activation, perhaps through cortisol levels.   This would 
provide evidence of the presence or absence of a physiological pathway in the relationship 
between psychological distress and diabetes outcomes.   
CCBT-SM takes advantage of the benefits of technology.  Future research should 
continue to capitalize on the evolution of technology to ensure the program remains relevant and 
appealing to patients.  Allowing users to access the program on smart phones and tablets would 
likely increase the utilization, as well as employing text message reminders and perhaps 
incorporating social media components.   
This study offers compelling evidence for the use of CCBT-SM in a diabetic population.  
However, the intervention employed did not address diabetes in any way.  The intervention had 
an affect on the symptoms of diabetes that are more psychological in nature and did not affect 
adherence or A1c.  Future research should explore changes to the program to more specifically 
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address these outcomes.  Numerous studies have shown that online diabetes self-management 
interventions are effective at improving adherence and diabetes outcomes (Ramadas, Quek, 
Chan, & Oldenburg, 2011).  The combination of those programs with CCBT-SM may provide 
the most comprehensive and impactful treatment for those with diabetes.  The benefits of 
including such components should be examined.  
Because of the lack of diabetes-specific information in the CCBT-SM program used in 
the study, this same program could be applied to other chronically ill populations as well as the 
general population.  The effectiveness of a generic CCBT-SM could provide primary care and 
other physicians with a very useful tool in the treatment of distress and improvement of physical 
health.  Future research should determine the program’s efficacy in other populations. 
In summary, this study provides evidence for the psychological and physical health 
benefits of CCBT-SM in a diabetic sample. It also supports an antecedent model of 
understanding the relationship between psychological factors and diabetes outcomes.  Further 
research should continue to explore the effect of the intervention on A1c as well as physiological 
pathways involved in the relationships. 
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Appendix A 
 
Original Homework Assignments 
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Stress	  Management	  
Identifying Negative Coping Strategies 
Stressor How I Felt (stress symptoms) 
How I  
Reacted How I Responded 
Do you rely on 
drugs, alcohol, 
smoking, or other 
negative behaviors 
to cope with stress? 
     
     
     
     
109 
Stressor How I Felt (stress symptoms) 
How I  
Reacted How I Responded 
Do you rely on 
drugs, alcohol, 
smoking, or other 
negative behaviors 
to cope with stress? 
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Stress	  Management	  
Embrace Positive Thinking 
Situation 
Identify the 
Negative 
Pattern 
 
Let your emotions  
be your guide. 
Evaluate your assessment of the situation 
Notice how you feel 
after you realistically 
assess  
the situation 
Evidence Alternatives Implications Usefulness 
What is the factual 
evidence that 
supports your belief? 
Are there other ways of 
looking at the situation? 
If the negative 
belief is true, ask yourself 
how bad is it? 
Does this type of 
pessimistic thinking serve 
any positive purpose? 
We are late 
to Sam’s 
soccer game 
I feel like an idiot 
for making us so late 
and having to rush;  
I feel defeated, 
depressed, anxious, 
and stressed 
I haven’t been late 
before; Sam 
knows I’m always 
there for him 
Being late isn’t idiotic; 
We’re involved in a lot 
of activities; Sam’s 
brother had a doctors 
appointment – that 
was a priority 
Being late isn’t the end 
of the world, nothing 
terrible will happen; 
Sam will still get to the 
game in time to play 
Worrying is a waste 
of my time; I will try 
to enjoy the game 
I feel much better now that I 
have realistically assessed the 
situation; now I can enjoy the 
game 
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Situation 
Identify the 
Negative 
Pattern 
 
Let your emotions  
be your guide. 
Evaluate your assessment of the situation 
Notice how you feel 
after you realistically 
assess 
the situation 
Evidence Alternatives Implications Usefulness 
What is the 
factual evidence 
that supports 
your belief? 
Are there other ways 
of 
looking at the 
situation? 
If the negative 
belief is true, ask 
yourself how bad is it? 
Does this type of 
pessimistic thinking 
serve any positive 
purpose? 
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Stress	  Management	  
Adopting Behavioral Strategies  
Rate your level of tension before and after you do your relaxation exercise.   
Use the following Scale: 
 
 1 2 3 4 5 6 7 8 9 10 
 Totally Relaxed                     Extremely 
 No Tension                     Tense 
 
Date 
& 
Time 
Tension  
Before 
Relaxation 
Type of  
Relaxation Exercise  
Tension 
After 
Relaxation 
Comments 
12/15/1
0 
 
2:00 pm 
8 
o Breathwork 
ü Progressive 
Relaxation 
o Guided Imagery 
o Meditation 
4 
This worked really well 
today, I felt much 
better after I 
relaxed! 
  o Breathwork 
o Progressive 
Relaxation 
o Guided Imagery 
o Meditation 
  
  o Breathwork 
o Progressive 
Relaxation 
o Guided Imagery 
o Meditation 
  
  o Breathwork 
o Progressive 
Relaxation 
o Guided Imagery 
o Meditation 
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Rate your level of tension before and after you do your relaxation exercise.   
Use the following Scale: 
 
 1 2 3 4 5 6 7 8 9 10 
 Totally Relaxed                     Extremely 
 No Tension                     Tense 
 
Date 
& 
Time 
Tension  
Before 
Relaxation 
Type of  
Relaxation Exercise  
Tension 
After 
Relaxation 
Comments 
12/15/1
0 
 
2:00 pm 
8 
o Breathwork 
ü Progressive 
Relaxation 
o Guided Imagery 
o Meditation 
4 
This worked really well 
today, I felt much 
better after I 
relaxed! 
  o Breathwork 
o Progressive 
Relaxation 
o Guided Imagery 
o Meditation 
  
  o Breathwork 
o Progressive 
Relaxation 
o Guided Imagery 
o Meditation 
  
  o Breathwork 
o Progressive 
Relaxation 
o Guided Imagery 
o Meditation 
  
  o Breathwork 
o Progressive 
Relaxation 
o Guided Imagery 
o Meditation 
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Stress	  Management	  
Problem Solving 
Recognize	  that	  there	  is	  a	  problem	  situation.	  
 
 
 
Define	  the	  problem.	  
 
 
 
 
Generate	  alternative	  solutions.	  
 
 
 
 
Take	  action	  on	  alternative(s)	  selected.	  
 
 
 
 
Evaluate	  the	  effectiveness	  of	  the	  solution	  chosen.	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Managing	  Your	  Mood	  –	  Helpful	  Lists	  
This worksheet includes spaces for you to try some of the different types of lists that are 
recommended in the managing your mood section of the program.  You don’t have to be 
depressed to find these lists useful.  Try each one for at least one day and see if they are helpful. 
 
Identify Harmful Thinking  
3 times a day, write down the most important emotion-related thoughts 
you’ve had since you last wrote.  Remember that important thoughts 
generate feelings and may occur repeatedly. 
Positive Thoughts                    Negative Thoughts 
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Make a gratitude list. 
Jot down situations that you are pleased about or people you appreciate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Make a list of your current accomplishments. 
This is the rewarding side of the “To Do List,” and most of us never write it! 
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Pleasant Activities 
Create a list of activities that give you feelings of pleasure or mastery.  You 
can go to this list when you need to get your mind off your troubles or when 
you find that you are engaging in too many activities that lead to sadness or 
anger. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Identify Positive People & Relationships in Your Life   
Loneliness	  can	  feed	  depression,	  but	  increasing	  contact	  and	  activities	  with	  likeable	  people	  can	  
lessen	  it.	  If	  social	  contact	  seems	  hard	  to	  maintain,	  a	  useful	  approach	  is	  to	  start	  with	  brief	  
outings	  with	  "safe"	  people.	  Friends	  and	  family	  can	  serve	  as	  a	  positive	  source	  of	  social	  support.	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Managing	  Anxiety	  
Challenging Threatening Thoughts 
Situation 
Identify the 
Threatening 
Thought 
What was I 
thinking when the 
anxiety began? Did 
I have a mental 
image? What did I 
think was going to 
happen? 
Evaluate your assessment of the situation 
Notice how you feel 
after you realistically 
assess  
the situation 
Evidence Alternatives Usefulness 
Thinking 
Errors 
What is the 
factual evidence 
that supports my 
belief? 
Are there other ways 
of 
looking at the 
situation? 
How does this type of 
thinking help me? 
Black & White 
Thinking, 
Unrealistic 
Standards, 
Catastrophic 
Thinking, 
Overgeneralizing, 
Overestimating the 
likelihood of bad 
events? 
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Situation 
Identify the 
Threatening 
Thought 
What was I  
thinking when the 
anxiety began? Did 
I have a mental 
image? What did I 
think was going to 
happen? 
Evaluate your assessment of the situation 
Notice how you feel 
after you realistically 
assess  
the situation 
Evidence Alternatives Usefulness 
Thinking 
Errors 
What is the 
factual evidence 
that supports my 
belief? 
Are there other ways 
of 
looking at the 
situation? 
How does this type of 
thinking help me? 
Black & White 
Thinking, 
Unrealistic 
Standards, 
Catastrophic 
Thinking, 
Overgeneralizing, 
Overestimating the 
likelihood of bad 
events? 
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Correlations Between Baseline and Final Assessments 
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Table B1 
 
Correlations Between Baseline and Final Assessment of all Variables 
 
Variable 
Correlation of Baseline & Final 
Assessments 
Perceived Generalized Stress .49** 
Diabetes-Related Distress  .70** 
Depression  .70** 
Anxiety  .60** 
Positive Affect  .65** 
Negative Affect  .64** 
Diabetes Symptoms (Total)  .71** 
Fatigue Symptoms  .71** 
Cognitive Symptoms  .75** 
Neurological Pain Symptoms  .69** 
Sensory Symptoms  .73** 
Cardiac Symptoms  .65** 
Ophthalmological Symptoms  .59** 
Hypoglycemia Symptoms  .51** 
Hyperglycemia Symptoms  .68** 
A1c  .87** 
General Diet Recommendations  .70** 
Specific Diet Recommendations  .70** 
Exercise Recommendations  .72** 
Glucose Testing Recommendations  .84** 
Foot Care Recommendation’s  .81** 
**p < .01. 
 
 
 
 
 
 
